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Like any real-world problem, the design of an imaging system always requires tradeoffs. 
For medical imaging modalities using ionization radiation, a major tradeoff is between diagnostic 
image quality (IQ) and risk to the patient from absorbed dose (AD). In nuclear medicine, reducing 
the AD requires reducing the administered activity (AA). Lower AA to the patient can reduce risk 
and adverse effects, but can also result in reduced diagnostic image quality. Thus, ultimately, it is 
desirable to use the lowest AA that gives sufficient image quality for accurate clinical diagnosis.   
In this dissertation, we proposed and developed tools for a general framework for 
optimizing RD with task-based assessment of IQ. Here, IQ is defined as an objective measure of 
the user performing the diagnostic task that the images were acquired to answer. To investigate IQ 
as a function of renal defect detectability, we have developed a projection image database 
modeling imaging of 99mTc-DMSA, a renal function agent. The database uses a highly-realistic 
population of pediatric phantoms with anatomical and body morphological variations. Using the 
developed projection image database, we have explored patient factors that affect IQ and are 
currently in the process of determining relationships between IQ and AA in terms of these found 
factors. Our data have shown that factors that are more local to the target organ may be more robust 
than weight for estimating the AA needed to provide a constant IQ across a population of patients. 
In the case of renal imaging, we have discovered that girth is more robust than weight (currently 
used in clinical practice) in predicting AA needed to provide a desired IQ. In addition to exploring 
the patient factors, we also did some work on improving the task simulating capability for 
anthropomorphic model observer. We proposed a deep learning-based anthropomorphic model 
observer to fully and efficiently (in terms of both training data and computational cost) model the 
 iii 
clinical 3D detection task using multi-slice, multi-orientation image sets. The proposed model 
observer is important and could be readily adapted to model human observer performance on 
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Like any real-world problem, the design of an imaging system always requires optimizing 
tradeoffs for a given task. For medical imaging modalities using ionizing radiation, a major 
tradeoff is between diagnostic image quality (IQ) and the risk to the patient from absorbed 
radiation dose. In nuclear medicine imaging, reducing the radiation dose to the patient will always 
increase the Poisson noise in the image, which may result in decreased IQ, resulting in unreliable 
images and even diagnostic errors. However, reducing the radiation dose (RD) on the other hand 
will always decrease the risk of adverse effects to the patient. Thus, it is critically important to use 
the “just right” amount of RD for each individual patient that maximizes diagnostic benefits while 
maintaining minimum adverse effects to the patient. This need for children patients is more 
pressing as they are more vulnerable to radiation than adults. 
In nuclear medicine, reducing RD is achieved through the reduction of the administered 
activity (AA). In current clinical practice, AA for pediatric molecular imaging is often based on 
the North American consensus guidelines (U.S.) and the European pediatric dosage card (Europe). 
Both of these dosing guidelines involve scaling the adult AA by patient weight, which subject to 
upper and lower constraints on the AA. However, these guidelines were developed based on expert 




measures of performance on the diagnostic task. Accurate quantification of IQ plays an important 
role in the IQ-RD tradeoff analysis. However, acquiring an accurate measure of IQ is not easy as 
it is not only dependent on AA but also many other factors such as the imaging system, patient 
body morphometry, reconstruction and compensation methods and post-reconstruction processing, 
etc. The overall goal of this research is to pin down the most significant factors that affect IO in 
renal nuclear medicine imaging and to develop a rigorous and comprehensive IQ-RD tradeoff 
analysis framework applicable to all medical imaging modalities using ionizing radiation. The 
results of this study will provide information for standards bodies to improve current dosing 




This dissertation is organized as follows.   
Chapter 1 states the significance and organization of this dissertation. 
Chapter 2 reviews the background of this work, previous researches in this area, and the 
technologies that underline it. First, this chapter describes the clinical imaging procedure, 
including the imaging modality and the chemical tracer used, that this study is aimed to optimize. 
Secondly, the method of task-based image quality assessment is discussed and existing model 
observers are reviewed. Finally, a brief description about convolutional neural network is provided 





Chapter 3 is a peer-reviewed journal publication which describes the initial work of 
developing a SPECT projection image database for a population of pediatric patients. The chapter 
outlines the methods for image simulation that were used throughout this research [1]. 
Chapter 4 is a peer-reviewed journal publication that describes our findings about a new 
external body parameter, which has better performance than weight (currently in clinical use) on 
predicting the AA needed to provide a desired IQ in renal nuclear medicine imaging [2]. Results 
show that factors that are more local to the target organ may be more robust than weight for 
estimating the AA needed to provide a constant IQ across a population of patients. We found that 
in the case of renal imaging, girth is more robust than weight in predicting AA needed to provide 
a desired IQ. 
Chapter 5 is a submitted manuscript that describes the design of a deep learning based 
anthropomorphic model observer (DeepAMO) that can be used for clinically realistic visual 
detection tasks performed on volume images. Results show that the proposed model observer has 
the potential to mimic human observer in performing defect detection task in a clinically realistic 
diagnostic setting. 
Chapter 6 summarizes the novel findings of this dissertation, highlights the significance and 
importance of this work to medical imaging system optimization and suggests potential avenues 








2.1 Nuclear medicine imaging 
 
2.1.1 Introduction to nuclear medicine imaging 
 
Nuclear medicine (NM) imaging is a branch of functional imaging that encompasses two 
main modalities – single-photon imaging, including planar scintigraphy and Single Photon 
Emission Computed Tomography (SPECT), and Positron Emission Tomography (PET) – which 
use small amounts of radioactive materials called radiotracers to provide in vivo imaging of 
functional and physiological processes of the human body [3]. It is distinguished from modalities 
such as X-ray planar radiography that principally depicts the body’s structure (anatomy). A 
radiotracer is a chemical compound where one or more of the atoms is a radionuclide. By nature 
of its biological and biochemical properties, the radiotracers can be used to explore the mechanism 
of physiological processes in vivo, such as glucose metabolism, by tracing the gamma photons 
emitted through the decay of the radioisotope. In single-photon imaging, a gamma camera is used 
to detect the gamma photons and produces a set of 2D projection data of the 3D radiotracer 
distribution within the patient body. In SPECT, projections are acquired at several views around 
the body, and the resulting set of projection data is reconstructed to provide 3D volume image of 




2.1.2 Radiation dose and image quality tradeoff in pediatric nuclear 
medicine imaging 
 
For medical imaging with ionizing radiation, there is always a tradeoff between image 
quality (IQ) and risk to the patient from absorbed dose (AD). In the dose range relevant to most 
nuclear medicine studies (below 10 mSv), the patient risks are specifically referring to a low-
probability risk of inducing caner (from stochastic effects) in the patient later in life. Children are 
thought to be at a higher risk of certain adverse effects from radiation exposure than adults owing 
to the enhanced radiosensitvity of their tissues and the longer time-period over which stochastic 
radiation effects may manifest [4]. Thus, it is particularly important to expose pediatric patients to 
as low a radiation dose as is commensurate with providing sufficient diagnostic information [5].  
In nuclear medicine imaging, reducing the AD requires reducing the administered activity 
(AA). Lower AA results in increased Poisson noise (introduced in section 2.4.1) in the images or 
requires longer acquisition durations to maintain the noise level. Thus, finding the optimal AD, 
i.e., the one giving the lowest risk sufficient to provide acceptable diagnostic image quality, comes 
down to finding the lowest AA that gives sufficient IQ for clinical diagnosis or other relevant tasks.  
The fundamental differences that separate pediatric nuclear medicine from adult nuclear 
medicine are that children generally have smaller organs and lesions [3] and are thought to be at a 
higher risk for adverse effects from radiation exposure than adults [4]. Therefore, special 
considerations are needed for imaging children. First, higher resolution images are needed in 
pediatric nuclear medicine in order to detect these smaller organs or lesions [3], as detectability of 
a lesion is fundamentally limited by the lesion size with respect to the resolution of the imaging 
system. Second, sedation is often required for children of young age and, especially for longer 
acquisitions. Longer acquisition durations increase the chance of patient motion, which can 
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degrade image quality. Short acquisition durations are thus desirable. Lastly, AA for pediatric 
nuclear medicine needs to be carefully optimized due to the potentially higher radiation-induced 
cancer risk of children. A detailed discussion about dose sensitivity in children is given in section 
2.2.2. 
 
2.2 Radiopharmaceutical dosing in nuclear medicine 
imaging 
 
2.2.1 Relationship between administered activity and radiation dose 
 
In nuclear medicine imaging, the total AD to a patient is proportional to the amount of 
administered activity injected to the patient. Here, the absorbed dose is defined as the mean energy 
deposited to the target tissue (or region) per unit tissue mass. According to the Medical Internal 
Radiation Dose (MIRD) schema [6], the absorbed dose to a target region of interest is computed 
as follows: 
 𝐷(𝑟𝑇 , 𝑇𝐷) =  ∑ ?̃?(𝑟𝑠, 𝑇𝐷)𝑆(𝑟𝑇 ← 𝑟𝑠),𝑟𝑆  (2.1) 
 
where 𝐷(𝑟𝑇 , 𝑇𝐷) is the mean absorbed dose to a target region of interest 𝑟𝑇 over a dose integration 
period 𝑇𝐷; ?̃?(𝑟𝑠, 𝑇𝐷) is the time integral of activity in the source region 𝑟𝑠; and 𝑆(𝑟𝑇 ← 𝑟𝑠) is the so 
called “S-value” in the field of dosimetry, which represents the absorbed dose per unit time-
integrated activity. The S-value depends on the average energy and abundance of the particle or 
particles emitted during the decay, the fraction of the energy that is absorbed in the target region, 




2.2.2 Dose sensitivity in children 
 
Children are often thought to be more sensitive to adverse effects from radiation exposure 
than adults [7]. This is mainly because children have: (1) more tissues with high mitotic rates, 
which are more vulnerable than tissues with lower mitotic rates to radiation [8], and (2) longer 
post-exposure lifespans to manifest these stochastic radiation effects [5]. In infancy and early 
childhood, these considerations become even more pressing, as cells are growing (undergoing high 
rates of division) and differentiating into mature cells, and thus are more vulnerable to ionizing 
radiation [9]. Although the cells attempt to repair themselves when they are damaged (mostly in 
the form of DNA breaks), very rarely, however, mistakes do happen in the DNA repair process, 
resulting in genetic abnormalities (mutations) [10, 11]. Therefore, there has been significant 
interest in the nuclear medicine community in establishing universally accepted and optimized 
dosing guidelines for pediatric nuclear medicine studies. 
 
2.2.3 Current dosing guidelines for pediatric nuclear medicine 
imaging and limitations 
 
To address the dosing of pediatric patients, the European Association of Nuclear Medicine 
(EANM) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) have published, 
respectively, the European pediatric dosage card and the North American consensus guidelines for 
pediatric administered activity (AA) [12, 13]. However, these guidelines were developed either 
based on a consensus of best practices or a simple estimation of image quality instead of a rigorous 
evaluation of diagnostic image quality relative to AA. A comprehensive introduction to the dosing 
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guidelines and their respective limitations is provided in Chapter 3 (terminology, such as count 
rate, effective dose, etc., is introduced in section 2.3).  
 
2.3 Renal functional imaging with 99mTc-DMSA SPECT 
 
2.3.1 Clinical problem 
 
99mTc-DMSA is the agent of choice for renal cortical imaging by planar, pinhole 
scintigraphy, or by SPECT [3]. The DMSA tracer is principally concentrated (1 hour or more after 
injection) in the proximal convoluted tubules of the kidneys, which is ideal for detecting cortical 
functional defects in pyelonephritis, infarction, scarring, duplication, and fetal lobations [3]. Fig. 
2.1 shows an example of SPECT image in pyelonephritis. The dim area, as indicated by the arrow, 
shows the non-functional regions of the cortex.  
 
 
Figure 2.1.  Example of a clinical SPECT image in pyelonephritis of a 16-year-old reconstructed using two 
iterations of eight subsets of the OS-EM reconstruction with detector response compensation followed by a Gaussian 




2.3.2 Use of DMSA in diagnosing acute pyelonephritis 
 
2.3.2.1 99mTc-DMSA Characteristics 
 
99mTc is one of the most commonly used medical radioisotopes in nuclear medicine 
imaging. It has a half-life of 6 hours [14] (93.7% of it decays in 24 hours) and emits pure gamma 
rays with a single photon energy of 140 keV. This energy is high enough that the photons leave 
the body, but low enough that the photons can be detected and collimated with relative ease.  99mTc 
labeled Dimercaptosuccinic acid (DMSA) was first developed by Lin et al. [15] as a renal imaging 
agent to replace the 197Hg-labeled chlormerodrin because of the poor imaging characteristics of 
197Hg, and the toxicity of mercury [16]. DMSA has a high absolute renal concentration, about 
twice that of the other 99mTc labeled compounds in humans, approaching the concentration of 
labeled chlormerodrin [17]. The physical characteristics of 99mTc and the mercurial-like kinetics 
of the chelator make this compound a unique agent for imaging the renal parenchyma in patients 
of all ages [18]. Moreover, DMSA has a high uptake in the renal cortex, with about 50% remaining 
there at 1 hour, resulting in a high gamma flux, and is thus ideal for imaging [19]. 99mTc-DMSA is 
the most commonly used agent for renal cortical imaging in planar scintigraphy and SPECT [20]. 
2.3.2.2 Biokinetic behavior of 99mTc-DMSA  
 
99mTc-DMSA is administered intravenously with a usual dose in adults of 0.05 mCi/kg 
(1.85 MBq/kg) [20]. After intravenous injection, this agent is 90 % bound to plasma proteins, and 
only a small amount (0-5%) is associated with red cells [19]. The clearance of 99mTc-DMSA in the 
blood follows a single exponential with a mean half-life of 56 minutes and with 6-9% of the 
administered dose present in the blood at 14 hours after injection [20]. The blood clearance of 
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99mTc-DMSA is very slow compared to other renal agents. The renal uptake of 99mTc-DMSA is 
approximately 40-50 % of the injected dose at 4 hours post-injection [19]. Most accumulated tracer 
is found in the proximal convoluted tubules, with small amounts elsewhere in the kidneys [21]. 
Although most 99mTc-DMSA is retained in the renal parenchyma, cumulative urinary excretion 
has been reported to be 6 % at 1 hour, 1-12 % at 2 hours, and 25 % at 14 hours [20]. 
According to the International Commission in Radiological Protection (ICRP) model [22], 
an intravenous injection of  99mTc-DMSA gives rise to an initial distribution in the extracellular 
fluid. About half of the material entering the extracellular fluid is deposited in the renal cortex and 
is retained there for a long time, and a further fraction is temporarily retained in the liver and spleen 
[22]. Excretion of 99mTc-DMSA is exclusively via the kidneys and could take up to 2 days [23]. 
 
2.3.3 Diagnostic task with DMSA SPECT 
 
Often, the associated diagnostic task for DMSA renal imaging is to detect renal 
parenchymal defects or cortical functional defects. Thus, we have modeled the clinical task as a 
defect detection task. As mentioned in section 2.4.3.3, there are some practical limitations of the 
current model observers. To overcome these limitations, we have developed a deep learning-based 
anthropomorphic model observer to fully simulate clinical detection task for DMSA renal SPECT 
imaging. The new model observer will be introduced in Chapter 5. The next section provides a 
general background about deep convolutional neural networks and their applications as model 




2.4 Image quality in nuclear medicine imaging 
 
In nuclear medicine imaging, there are two fundamental methodologies for evaluating 
image quality [24]. The first is by means of physical characteristics that can be quantitatively 
measured for the image or imaging system. The second is by means of task-based image quality 
evaluation such as human observer studies (a detailed introduction is provided in section 2.4.3)  
2.4.1 Physical characteristics of image quality 
 
In order to understand the surrogate measures of image quality used in Chapter 3, it is 
essential to introduce the physical characteristics of image quality for nuclear medicine images.  
In principle and among other factors, the quality of nuclear medicine images is mainly 
characterized by three factors: (1) spatial resolution (sharpness), (2) noise (variations in the image 
due to random effects such as quantum noise), and (3) contrast (difference in image intensity 
between areas of the imaged object). Other factors such as artifacts, non-uniformity or distortions, 
and patient or organ motion can also affect image quality but will be largely neglected in the 
following discussion. Although resolution, noise, and contrast describe three different aspects of 
image quality, they cannot be treated as completely independent parameters: improvement in one 
is frequently obtained at the expense of deteriorating the others [24]. For example, in nuclear 
medicine, reduced image noise can be obtained by the use of a higher sensitivity collimator. 
However, there is an inverse relationship between sensitivity and resolution, thus reducing noise 
via the use of a high sensitivity collimator results in poorer spatial resolution. Poor spatial 
resolution will result in poorer contrast of small objects.  
Spatial resolution refers to the ability of an imaging system to separate fine details in the 
image [25]. There are two main components that contribute to the lack of details or sharpness in 
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nuclear medicine: geometric resolution and intrinsic resolution (detailed introduction is provided 
in section 2.4.3.1). In theory, the higher the spatial resolution of the imaging system the shaper the 
image it can produce. However, there is a tradeoff between spatial resolution and noise. For 
example, improved collimator resolution results in decreased collimator efficiency, and, hence, 
decreased counting rates and increased image statistical noise for the same acquisition duration 
and administered activity.  
In nuclear medicine, noise most often refers statistical fluctuations in the recorded counts 
that result from the random nature of radiation decay and photon counting statistics. These 
fluctuations can be described using the Poisson distribution: 
 





where 𝑚 is the mean number of detected counts in a projection bin and 𝑛 is the number recorded 
counts for one particular acquisition. The fact that the recorded counts can be different from the 
mean is referred to as Poisson noise. In projection data, the noise is uncorrelated Poisson noise 
whose variance 𝑉𝑎𝑟[𝑁] equals its expectation 𝐸[𝑁]. In general, the only way to reduce the amount 
of Poisson noise is to increase the mean number of counts. This can be seen by considering the 
coefficient of variation (COV), defined as the standard deviation divided by the mean, which 
describes the relative level of noise in a projection bin and is given by 
 







which shows that Poisson noise, while growing in absolute terms with the signal, is relatively 
smaller at higher count levels.  
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Reconstruction and other image processing can alter the magnitude of the noise 
fluctuations and change the noise texture (by introducing correlations) depending on the algorithm 
used. Noise is a very important aspect of nuclear medicine. When the size of an object is 
substantially larger than the limiting spatial resolution of the imaging system, noise can still impair 
detectability, especially when noise fluctuations are large compared to the contrast of the object of 
interest.  
Image contrast refers to the differences in counts or intensity in the object of interest 
compared to the background. In nuclear medicine, this difference is caused by the different levels 
of radioactive uptake in the patient [24]. For example, if 𝑅𝑏 is the number of counts recorded in a 
background area and 𝑅𝑠 is the number of counts recorded over a signal area (i.e., a lesion), the 






   
There are several factors that affect the contrast including intrinsic object uptake, 
scattering, and septal penetration. Among these factors, intrinsic object uptake is the major 
component that affects image contrast, and is largely determined by the radiopharmaceutical and 
patient biokinetics. The other two factors affect the image contrast primarily by adding counts to 
the background. The degraded image contrast with the added background 𝑅0 can be expressed as 
 
   𝐶𝑠′ =












It can be seen in the above equation that the larger the additional factor  𝑅0/𝑅𝑏 the more 
decrease would be seen in the contrast. Also, contrast is related to noise through the contrast-to-
noise ratio (CNR), which is a critical parameter for detectability. The CNR is defined as the 
contrast divided by the noise. One way to characterize noise is the COV of the recorded counts in 
the same area where the contrast is measured. A high noise level will have a large denominator 
(COV) in the CNR and thus a smaller CNR, resulting in reduced detectability and less accurate 
diagnosis. In nuclear medicine, image contrast can be degraded by physical factors involved in 
image formation such as the effects of scattered photons from surrounding tissues, and septal 
penetration and scatter. A detailed introduction to the causes and effects of photon scatter and 
septal penetration is given in section 2.4.2.1and 2.4.2.2, respectively. 
Although these physical measures set the fundamental limits for image quality in nuclear 
medicine imaging, they may not directly reflect the performance of an observer on a clinical task 
performed with those images. Clinically relevant image quality should be assessed with respect to 
the task that is to be performed [26-32]. 
 
2.4.2 Image quality in SPECT 
 
2.4.2.1 SPECT image formation process 
 
SPECT images originate from measurements of gamma photons emitted from the 
radiotracers distributed within the patient body. These photons are recorded by a gamma camera 
that is rotated around the patient to form multiple 2D images (also called projections), from 
different projection views. Then these projections are reconstructed to form a 3D image (of the 
radiotracer distribution of the body) using a tomographic reconstruction algorithm.  
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The process of projection acquisition is represented mathematically as follows 
 𝐠 = 𝐇𝐟 + 𝒏, (2.6) 
where 𝐟 = [𝑓1, 𝑓2, … , 𝑓𝑁]𝑻 ∈ ℝN×1  is the voxelized object being imaged (the continuous 3D 
radiotracer distribution of the body), 𝐠 = [𝑔1, 𝑔2 , … , 𝑔𝑀]𝑻 ∈ ℝM×1 is the projection image, and 
𝐇 ∈ ℝM×N  is the imaging operator, which maps the activity distribution to the measured 
projections, and 𝐧 ∈ ℝM×1 is the Poisson noise (introduced in section 2.4.1) resulting from the 
random nature of radioactive decay and interactions of the emitted photons with the patient and 
detection system. Specifically, 𝐇 is a matrix characterizing all the image degrading factors in the 
image formation process which includes the attenuation and scatter in patient and the collimator-
detector blurring (introduced in section 2.4.3), with 𝐇𝑖𝑗 representing the probability of a photon 
emitted in the image voxel 𝑗 to be detected in the projection bin 𝑖. Pictorially, the image formation 
process is illustrated in Fig. 2.2.  
The relative noise in the projections increases as a result of attenuation in the body due to 
decreased count rate (discussed in section 2.4.1), at a fixed AA and acquisition time. Attenuation 
is caused by the interaction of photons within the body (e.g., the photoelectric effect and Compton 
scattering), and leads to a depth-dependent reduction in the number of primary (unscattered) 
photon counts detected in the projection image. The amount of attenuation is dependent on the 
composition (e.g., atomic number and density), the energy of the photons, and the thickness of the 
absorber.  
 In theory and among other factors, the spatial resolution in SPECT (both axial and in-plane) 
is determined largely by the collimator resolution (the most important  component of which is the 
geometric component introduced in section 2.4.2.2) and the intrinsic resolution of the gamma 
camera [24]. The further away the camera is from the patient, the worse the resolution. Thus, it is 
 
 16 
desirable to use a body contour orbit that places the camera as close to the patient as possible at 
each projection view to acquire high-resolution image of the patient. 
 
 
Figure 2.2.  Illustration of the image formation process of SPECT 
 
2.4.2.2 Physical factors of image quality in SPECT 
 
In section 2.4.1, we discussed the physical measures that affect image quality in nuclear 
medicine imaging. In this section, we focus on discussing the factors that affect these physical 
measures in SPECT renal imaging in particular.  
In the projection domain, the PSF (introduced in section 2.4.1) that describes the spatial 
resolution of a source in air is simply the collimator detector response function (CDRF), which is 
the image generated from a point source of activity. In the presence of a medium (i.e., patient), the 
PSF is also affected by the attenuation and scatter in the medium in addition to the CDRF. Since 
the CDRF various with position, the PSF is spatially varying. In a patient, the PSF is affected by 
scatter and attenuation, and is thus patient-dependent. In the reconstruction domain, the camera 
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orbit and the reconstruction algorithm can also affect the PSF in addition to the CDRF. The CDRF 
includes the intrinsic, geometric, septal scatter, and septal penetration response components. Since 
the geometric component is distance-dependent, the CDRF is spatially varying. The intrinsic 
response is due to the uncertainty of position estimation in the camera’s detector system and the 
effects of scattering in the detector crystal. The geometric response accounts for all the photons 
from the point source that travels through the collimator holes without any interactions with the 
collimator septa and are detected in the acquisition energy window. The septal scatter and 
penetration components account for all the other photons that interact with or pass through the 
septa, respectively. For the 140 keV photons emitted by the agents used in renal imaging, septal 
penetration and scatter have relatively small effects on the CDRF.  
The relative noise level in SPECT, as measured by the COV (equation 2.3), is inversely 
related to the number of detected photons received by the gamma camera. The number of detected 
photons is largely determined by the activity in the target organ, which in turn depends on the 
following factors: (1) fraction of the AA taken up in the target organ; (2) the size of the organ; and 
(3) the amount of attenuating medium between the organ and collimator of the scanner. 
Attenuation refers to the loss of photons emitted from a source as they travel toward the detector 
due to interactions with the body. Attenuation results in a depth-dependent reduction in the number 
of detected primary photon counts as compared to the same source in the air. The amount of 
attenuation depends on the energy of the photons and the composition and thickness of the 
absorber. 
Scatter is another major effect that affects image quality (mostly contrast) during SPECT 
image formation. Scatter refers to scatter interactions (mostly Compton) in the patient. A scattered 
photon is a photon detected after it has undergone these scatter interactions. These scatter 
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interactions result in a change in the direction of the photons, and thus a loss in correlation between 
photon direction and the position of emission. These scattered photons can pass through the 
collimator and be detected, providing false position information and distortion of the estimated 
activity distribution. Scatter can cause the image to lose contrast by adding a low-frequency 
background of the image. To reduce the number of scattered photons counted in the projection 
image, energy discrimination is used to reject scattered photons. In this method, an acquisition 
energy is set around the energy window, centered on the energy of the gamma photon being 
imaged, and photons incident with energies outside this range are not counted. The scatter rejection 




The intrinsic contrast of a target object is determined by the activity uptake concentration 
of the target object relative to its surrounding tissue. The intrinsic contrast defines the upper limit 
of contrast that the imaging system can obtain for the target object, in a noise-free scenario with a 
perfect system PSF. When the target object is a defect, the intrinsic contrast of the defect affects 
the detectability of the defect, which would in turn affect image quality.   
 
2.4.2.4 Patient factors 
 
Besides system parameters, patient factors also have an important effect on image quality 
in SPECT. There are mainly three factors: (1) patient body morphometry local to the target organ; 
(2) patient target organ uptake; and (3) defect size versus imaging system resolution.  
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Patient body morphometry can have a direct impact on defect detectability. As an example, 
we found that patients with large girth at the location of the kidney can have lower image quality, 
as measured by defect detectability, than those with small girth [2]. The difference in image quality 
was due to a combination of three factors: the large girth patient resulted in fewer photons escaping 
the body, required a larger average camera orbit radius resulting in poorer spatial resolution, and 
produced a higher scatter-to-primary ratio, resulting in higher noise, poorer resolution, and poorer 
contrast, respectively, for the patient with a larger girth. 
In addition to patient body morphometry, the amount of tracer uptake specific to an 
individual patient can also affect defect detectability, as previously explained in section 2.3.3.3.  
Lastly, the defect size of the patient, which is unknown before imaging, can also affect 
defect detectability. To see details of a small defect with reasonable contrast, the spatial resolution 
must be better than the object size. Thus, it is generally preferred to use high-resolution collimators 
to image pediatric patients as children generally have smaller organs, and smaller defects are more 
clinically significant than adults.  
 
2.4.3 Task-based image quality 
 
2.4.3.1 Introduction to task-based image quality assessment 
 
As described above, the quality of a medical image can be measured in terms of physical 
characteristics of the image, such as image contrast, spatial resolution, and noise [33] using various 
physical metrics. Alternatively, fidelity-based measures such as root mean squared error (RMSE), 
peak signal-to-noise ratio (PSNR) and structural similarity index (SSIM), which evaluate image 
quality in terms of similarity of the image with respect to the imaged object, have also been widely 
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used in the medical imaging community. Fidelity-based measures are appealing because they are 
relatively easy to compute, have straightforward physical interpretations, and can provide 
objective quantitative measures of image quality. However, neither the physical nor fidelity-based 
measures are directly related to performance on the diagnostic task that will be performed with the 
images and thus may not be clinically relevant [31]. To be clinically relevant, image quality should 
be assessed with respect to a specific task that will be performed with the images [26-32], i.e., 
detect a tumor or estimate tumor volume. Assessing image quality objectively in terms of 
performance on a specific clinical task is called task-based image quality assessment.  
Typically, the task is performed by an observer, and the figure of merit for image quality 
is the performance of the observer on the task. In the vast majority of clinical tasks, the observers 
are humans, and thus the observers used in the assessment should be drawn from the population 
of people performing the task, i.e., for medical images, a radiologist or nuclear medicine physician.  
 
2.4.3.2 Human observers 
 
Humans serve as observers or expert readers in the vast majority of medical imaging 
applications in task-based image quality assessment studies [31]. Human observers are the most 
relevant in assessment of the images used by human observers to perform a task [31]. However, 
in practice, the use of human observers (and especially physicians) is practically extremely 
challenging and expensive, especially in large-scale developmental research studies. Furthermore, 
human observers exhibit a significant amount of intra-observer and inter-observer variability in 
performance [33]. Thus, models of human observers (anthropomorphic model observers) have 
been widely used as surrogates for human observers. A great deal of effort has gone into the 




In the context of a clinical defect detection task, the human observer is a radiologist or a 
nuclear medicine physician. However, the task to be performed in a human-observer study is 
slightly different from the routine clinical diagnostic task, i.e., classifying the patient as abnormal 
or diseased based on the image. For defect detection tasks, two-alternative forced-choice (2AFC) 
and continuous rating scale methods have been widely used in human-observer studies to allow 
measurement of a figure-of-merit for the observer’s performance [38, 39]. In the majority of the 
human-observer studies, the input to the human observer is either a single image (i.e., a short-axis 
slice), a stack of slices from a specific orientation, or a set of images from 3 orthogonal (e.g., 
transaxial, sagittal, and coronal) orientations. The output from the human observer is a rating value, 
which represents the confidence that the observer thinks that there is a defect present in the image. 
Fig. 2.3 shows an example of a human-observer study display window using a continuous rating 






Figure 2.3. Example of a human-observer study display window. The image is displayed in the bottom lower corner; 
the instructions are in the top right corner; the continuous rating scale is in the bottom right corner. Cross-
hair indicates a possible center of a defect to the observer. The study was for detecting renal cortical 
damage with DMSA SPECT images. 
 
2.4.3.3 Model observers 
 
Of the existing anthropomorphic observer models, the channelized Hotelling observer 
(CHO) has been the most widely used as a substitute for human observers in signal-location-known 
tasks in nuclear medicine imaging research [40]. The essential component that distinguishes a 
CHO from a Hotelling observer is the introduction of the concept of frequency channels. The 
channels are introduced for dimensionality reduction or to make the HO better model human 
observers [31]. There is widely accepted psychophysical evidence that, when visually processing 
an image, humans are sensitive only to the total power in a series of frequency bands or channels 
rather than to individual frequencies (infinitesimally small frequency bands) [41]. Thus, the entire 
frequency content of an image within a given frequency band or channel can be reduced to a single 
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output channel value. This process is often called channelization, which involves multiplying (in 
frequency domain) or taking dot products (in spatial domain) of the input image with a series of 
channel template images (shown in Fig. 2.4). The resulting scalar can be considered as the energy 
contained in the frequency channel. A total of N frequency channels results in an N-dimensional 
vector, often referred to as a feature vector  [33]. For example,  
 
 𝒗𝑖 = 𝒖𝑖𝑡𝒈, (2.7) 
 
where 𝒈 is the original input image,  𝒖𝑖 is the ith channel template image, and 𝒗𝑖 is the ith channel 
response. Stacking the channel responses together results in a feature vector 𝒗,  
 
 𝒗 = (𝑣1, 𝑣2, 𝑣3, 𝑣4, … 𝑣𝐿), (2.8) 
 
 
Figure 2.4.  Images of 4 anthropomorphic difference-of-mesa [42] channels in the frequency-domain (top row) and 
their corresponding shifted spatial domain template images (bottom row). The cross-hair indicates the 
center of the template, which must be aligned with the center of the suspected defect location when 
taking the dot product.  
 
For a binary detection task, the CHO test statistic 𝜆 is computed by taking the dot product 
of the CHO template and the channelized data vector 𝒗 [43]: 
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 𝜆 = 𝒘𝑡𝒗, (2.9) 
 
where 𝒘 is the CHO template vector and the superscript 𝑡 denotes the transpose operation. The 
CHO template is generated using the 1st and 2nd order statistics of the channelized data vector and 
is given by [43]: 
 𝒘𝑡 = (〈𝒗1〉 − 〈𝒗2〉)𝑡𝑲𝑔−1, (2.10) 
 𝑲𝑔 = 𝑃1𝑪1 + 𝑃2𝑪2, (2.11) 
 
where 〈𝒗1〉 and 𝑪1 are the mean vector and covariance matrix of the channelized data vector 𝒗 
under the hypothesis 𝐻𝑖 (𝑖 = 1,2). 𝑃1 and 𝑃2 are the occurrence probabilities (prevalences) for the 
two classes.  
The CHO has been shown to correlate well with human observer performance on signal-
known-exactly/background-known-exactly (SKE/BKE) tasks [44, 45], SKE-background known 
statistically (BKS) (e.g., lumpy backgrounds) tasks [46], and SKE-realistic anatomical 
backgrounds tasks [38, 41, 47] for a variety of types of nuclear medicine imaging. However, in 
those tasks the observer is only asked to decide whether the defect is present or not at a specified 
location. A more clinically realistic detection task is the signal-known-statistically (SKS)/BKS 
task, where variability can be present in both the signal and background. Here, signal variability 
is present in the form of variations in signal/defect shape, size, orientation, or topology/texture or 
combinations of the above. Background variability can come from two sources: quantum noise 
and anatomical variability. Modeling the latter is important in order to model clinical task where 
patients can vary greatly in size, shape, uptake, etc. It is important to model these image features, 
especially in studies such as virtual clinical trials, in order to accurately model performance on 
images from patient populations. For these clinically more realistic SKE/BKS and SKS/BKS tasks, 
there is evidence that rankings or ranking trends of human observers and the CHO are correlated 
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for different noise levels [47, 48], reconstruction methods and phantom populations [49], imaging 
systems [50], compensation methods, and post-filter cutoff frequencies[51]. Scanning forms of the 
CHO can be applied for the clinically more realistic SKS/BKS tasks to analyze each location 
within a particular region of interest (ROI) as a potential defect site [52]. However, the location-
specific nature of the defect profile for the scanning CHOs will be a problem if there are extensive 
search areas and defect profile variability with respect to location is relatively high [53]. From an 
implementation perspective, for SKS tasks with a large search region and a high signal variability, 
the use of scanning CHO can be computationally demanding (even with the use of channels). 
Specifically, the scanning CHO requires computing covariance matrices numerically for every 
single pixel within the search region, which can be a problem for input image that has an 
extensively large search region such as multi-slice, multi-orientation image sets. Furthermore, 
scanning observers do not model the human’s process of confirming a defect in slices across 
multiple orientations. For these reasons, the previous attempts to use scanning observers on multi-
orientation, multi-slice images have focused on reducing the search region. The main techniques 
include using of a front-end search process [53] to obtain a subset of the original search location 
set (reduce the number of slices that analyzed by the scanning observer) and simplifying the defect 
confirmation process by simulating a simpler SKE/BKE detection task, etc. [54, 55] 
In addition to the above limitations, existing model observers often predict rankings but 
not the absolute performance of human observers [56-59]. For imaging system optimization or 
comparison studies, this can be sufficient, but for other applications, such as selecting imaging 
time, administered activity, or radiation dose, prediction of absolute performance measures is 
required [32]. Obtaining absolute agreement for these model observers typically is done with the 
addition of observer internal noise [56]. The calibration process is a parameter search exercise 
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where the goal is to find the value of an internal noise parameter that matches performance between 
the model and human observers. Note that the calibration process is often performed for one 
specific combination of signal (shape, size, and orientation) and noise level, and it is unclear the 
degree to which the calibration generalizes to other situations. 
In an attempt to resolve the limitations described above, we proposed a novel deep 
learning-based anthropomorphic model observer (DeepAMO) in Chapter 5. The proposed model 
observer can evaluate multi-orientation, multi-slice image sets to model the clinical diagnostic 
process of a radiologist or nuclear medicine physician in a clinically realistic 3D defect detection 
task. The DeepAMO was evaluated on an SKS/BKS tasks using a realistic anatomical background 
with variation in organ uptake and defect position (and thus orientation and shape). We also 
proposed a novel calibration method that ‘learns’ the underlying distribution of the human observer 
rating values (including the internal noise) using a Mixture Density Network. In the next section, 
we will introduce the fundamentals of convolutional neural networks (a deep learning algorithm) 
as well as review some of the current model observers that are based on convolutional neural 
networks. 
 
2.5 Review of the current model observer based on 
Convolutional neural network  
In this section, we will first give a brief introduction to convolutional neural networks 
(CNNs) from the perspective of object detection, which is a classic computer vision problem that 
is closely related to the defect detection problem of interest to this dissertation. There, we will 
introduce CNNs in the context of object detection, which includes the problem formulation, the 
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backpropagation algorithm, and the functionalities of some essential layers that have been widely 
used in object detection. Finally, we will review two recently published CNN-based model 
observer publications aimed at reproducing a human observer’s defect detection performance, 
summarize the limitations in them, and finally state the aims of the proposed model observer in 
Chapter 5.  
2.5.1 Introduction to convolutional neural network 
 
A CNN is a deep learning algorithm that has been widely used in compute vision for 
recognizing and classifying features in images  [60-63]. It is a multi-layer neural network originally 
designed to analyze visual inputs and perform tasks such as object detection, image recognition 
and classification. With successful experimental results and wide applications in computer vision, 
the use of CNN has become increasingly popular in the medical imaging community, particularly 
in medical image analysis, computer-aided diagnosis, radiotherapy, and task-based image quality 
evaluation.  
2.5.1.1 Object detection with convolutional neural network 
2.5.1.1.1 Loss function 
 
The loss function works as the steering wheel for a neural network by defining the objective 
function and boundary for the task of the network. The loss function provides a measure of the 
difference between the output of the neural network for a given input and the desired (true) output. 
Depending on the application of the neural network, the loss function can be very different. The 
object detection problem that is most relevant to this dissertation is a one-class object detection 
problem, of which the goal is to detect an object’s presence in an image. For this task, the binary 




where 𝑦𝑖 is the ground truth label or target value (-1 or +1) for the 𝑖th image and ?̂?𝑖 is the predicted 
label (a probability) for the 𝑖th image. N is the output size which is the number of images in the 
model output.  
During training, the parameters (weights) of a network are updated by the update terms, 
which are the negative derivatives of the loss with respect to the weights times a small change 𝛿, 
referred to as the learning rate. The algorithm used to calculate the gradient of a loss function with 
respect to the weights (local parameters) is called backpropagation, short for “backward 
propagation of errors”. The backpropagation algorithm is introduced formally in section 2.5.1.2.2. 
 
2.5.1.1.2 Architecture of a CNN 
 
The architecture of a network can be understood as a way to achieve the objective defined 
by the loss function. In this section, we will introduce the problem formulation of the one-class 
object detection problem. 
 
 
𝐿𝐵𝐶𝐸(?̂?𝑖 , 𝑦𝑖) =  −
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Figure 2.5.  Illustration of the problem formulation for a one-class object detection problem 
For a 2D object detection problem, the input to the network is a 2D image data, and the 
output is a predicted label for the input image. Typically, there are two main parts to a CNN 
designed for performing such task: (1) a feature extractor that is based on convolution responsible 
for producing various features of the image for analysis, and (2) a fully connected layer that uses 
the output of the feature extractor to select the best label for the image. A pictorial illustration of 
the problem formulation is shown in Fig. 2.5.  
 In the next section, we will introduce the basics of the modern CNN for object detection 
and provide a high-level view of why these networks have been some of the most influential 
innovations in the field of compute vision and medical image analysis. 
2.5.1.2 Basics of the modern CNN for object detection 
 
To understand how a modern CNN learns to detect an object in an image, we first need to 
understand backpropagation, the most widely used algorithm for training a neural network. In the 
following section, we will introduce backpropagation in the context of multi-layer perceptron, the 
precursor of the modern CNN, the reasons for use of convolution in analyzing visual data, and the 
basic layers in a modern CNN. 
 
2.5.1.2.1 Multilayer perceptron 
 
 
The idea of a multilayer perceptron is to address the limitations of a single-layer perceptron, 
namely, it can only classify linearly separable data into binary classes (1,−1) [65]. A single-layer 
perceptron is a feed-forward network based on a threshold transfer function and has the structure 





Figure 2.6.  Illustration of a single-layer perceptron 
 
A multilayer perceptron (MLP) is built on top of single-layer perceptron. In an MLP, the 
outputs from one layer are used as inputs to the next layer. Therefore, many layers can be specified 
to model complex non-linear relations between the inputs and outputs. The capacity of the MLP 
is related to the number of hidden units within it. More hidden layers (any layers in between the 
output and input layer) mean more parameters and thus greater capacity of the MLP; however, 




Figure 2.7.  Illustration of a multilayer perceptron 
The red nodes in the figure above represent the original part from the single layer 
perceptron that is shown in Fig. 2.5. The essential components that make an MLP differ from a 
single-layer perceptron are: (1) a soft thresholding function after each summation (linear 
combination of inputs), and (2) hidden layers. In theory, any complex non-linear relationship can 
be modeled by an MLP with enough hidden layers [66]. Thus, an MLP is often preferred over 
single-layer perceptron in modeling more sophisticated data, such as linear inseparable data, due 
to its ability to capture complex non-linearity. 
2.5.1.2.2 Backpropagation 
 
Backpropagation refers to application of the chain rule many times to calculate the gradient 
of a loss function with respect to the weights in a network. Fig. 2.8 shows a simple network 
containing only three inputs, two operations, and a single output. To understand backpropagation, 
we need to first answer the following question: how much change there is on the final result if the 
input is changed by an amount of 𝛿. That is, in the example shown in Figure 2.8, how would 
change in 𝑎 affect 𝑓, which is the final result of the network. To answer this question, we need to 
calculate the partial derivative with respect to that particular input, which is 𝜕𝑓/𝜕𝑎 =  5 in the 
example. This simply means that an increase in 𝑎 would increase 𝑓 by an amount equal to 5 𝛿 (𝛿 
here denotes the change in 𝑎 itself). In general, a positive gradient would positively influence the 
loss (the final result) and a negative gradient would negatively influence the loss, by the amount 
that is equal to the gradient multiplied by ∆. In a real neural network or a large computational 
circuit (imagine a very large number of operations and inputs), we can think 𝑎 as one of the weights 
𝜔 and 𝑏 as one of the inputs 𝑥 such as the ones shown in Figure 2.8. In the update equation, if we 
want to decrease the loss, we just need to update the weight by a tiny bit in the opposite direction 
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of its local partial gradient, i.e., decrease 𝜔 from -2 to -3. Doing so would give a smaller value of 
the loss function, 𝑓. 
 
 
Figure 2.8.  A pictorial illustration of backpropagation 
 
To train an MLP, we have to estimate the weights of the perceptron. First, we need to 
calculate the loss, which acts as an indication of the error between the output of the network and 




Figure 2.9.  A sample MLP for demonstration of backpropagation 
 






As explained above, the update terms are the negative derivatives of the loss with respect to the 
local parameters (weights) times a small change 𝛿, referred to as the learning rate: 
 
 
which is computed by the chain rule, and  
 
 
which is computed directly as they are weights of the last layer. By defining 𝑧𝑚 = 𝜎(∑ 𝜔𝑚𝑛𝑥𝑛𝑛 ), 






and, its derivative as: 
 
 









 ∆𝜔𝑚𝑛 = −
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× 𝛿, (2.14) 
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× 𝛿, (2.15) 
 






























And, finally, we have 
 
 
where ∑ (𝑦𝑖 − ∑ 𝜐𝑖𝑚𝑧𝑚𝑚 )𝑖  is the error calculated at the output layer. 
 
2.5.1.2.3 From MLP to modern CNN 
 
For an MLP, the inputs are always 1D vectors. However, an image is a 2D vector and the 
structural information among the neighboring pixels or voxels does represent a great deal of 
information provided by the image. Vectorizing the image to a large 1D vector results in an 
oversized matrix of input weights. Consider a 2D image of size 23 × 23 (shown in Fig. 2.10) for 
which we would have 529 input nodes. If the hidden layer has 200 nodes, the size of the matrix of 
input weights would be 529 × 200 = 105,800. This is just the first layer, and as we increase the 
number of layers, the matrix size increases even more rapidly. Furthermore, vectorization 


































Figure 2.10.  Illustration of an MLP on 2D image data 
As early as 1987, researchers had started to explore the use of convolutional neural 
networks (CNN) to overcome both of these disadvantages. In 1998, the first work on modern 
CNNs was introduced by Yann LeCun for handwriting recognition [67]. In that paper, LeCun 
demonstrated that a CNN was able to aggregate simpler features into progressively more complex 
features, which could then be successfully used for handwritten digit recognition.  
The fundamental difference between a CNN and an MLP is the addition of 2D convolution. 
2D convolution has multiple unique advantages when it comes to processing 2D images. First, it 
can replace the computationally expensive matrix multiplications required by an MLP as learning 
a set of convolutional filters (each of 3x3) is much more tractable than learning a large matrix of 
millions of parameters [63]. Second, the 2D convolution filters can provide local connectivity  (on 
the order of the size of the filter used) and weight-sharing (the same filter applied across the image) 
[68]. Third, the 2D convolution can naturally account for 2D spatial structural information in the 
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image [68]. As a result of the combination of these advantages and the great leap computational 
performance provided by GPUs, the CNN has enjoyed a huge surge in use after the AlexNet 
achieved state-of-the-art performance labeling of pictures in the ImageNet challenge [60].  
 
2.5.1.2.4 Convolution layer 
 
The most fundamental operation in a CNN is convolution. The role of a convolution layer 
is to detect local features at different locations in the input image, producing feature maps [68]. A 
convolution layer is essentially a set of learnable kernels or filters. A feature map is an output 
obtained by applying a filter in the convolution layer to an image. The image can be the input 
image or another feature map resulting from a preceding convolution layer. To calculate a set of 
feature maps for a convolution layer 𝑙, we need the feature maps in the preceding layer 𝑙 − 1 and 
the filters in the current convolutional layer. Mathematically, the feature maps resulting from the 
convolution layer 𝑙 are given by [68]: 
 
where 𝑀(𝑙−1) is the number of feature maps in the layer 𝑙 − 1, ∗ denotes a convolution in the 
spatial domain, 𝑏𝑗
(𝑙) is a bias parameter, and 𝑓(∙) is a nonlinear activation function. The gradients 
or the derivative of a loss function with respect to the filter weights at a particular layer are 
computed by backpropagation as described in section 2.5.1.2.2. However, since the same filter 
kernel (i.e., set of weights) is applied multiple times at different locations in the image or feature 
map, the total derivative of the loss function with respect to the filter weights becomes a total 












derivative of the loss with respect to the filter determines how much change in the filter weights 
will be needed in each iteration of training. In the following sections, we will introduce two other 




A CNN is usually composed of a series of convolutions intersected by nonlinearity 
operations. Nonlinearity operation in CNN is like the soft thresholding function in an MLP 
(introduced in section 2.5.1.1). It is essential as cascading a series of linear systems (like 
convolution) results in another linear system. By introducing the nonlinearities in between the 
layers, the model can be more expressive than a linear model [68]. Some of the most widely used 
nonlinearity functions include sigmod ( 𝜎(𝑥) = 1
1+𝑒−𝑥
), tanh ( 𝑡𝑎𝑛ℎ(𝑥) = 1
1+𝑒−𝑥
), and ReLU 
(𝑅𝑒𝐿𝑈(𝑥) = 𝑚𝑎𝑥(0, 𝑥)). 
 
2.5.1.2.6 Pooling layer 
 
A pooling layer is another building block of a CNN. The purpose of a pooling layer is two-
fold: (1) reduce the spatial dimensionality of the feature maps, and (2) provide a small degree of 
spatial invariance. One limitation about convolution layer is that they can only produce feature 
maps that record the precise position of the features in the input image. A small shift in the position 
of the features in the input image will thus result in a different feature map. A pooling layer solves 
this problem by providing a lower resolution of the feature map which still contains the important 
structural information in the feature map, but without the fine details that may not be useful to the 
task. At the meanwhile, the number of parameters and amount of computation need to be learned 
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in the later layers are drastically reduced. Among the different types of pooling operations, the 
most commonly used pooling is max-pooling. A max-pooling layer is essentially a 𝑛 × 𝑛 max 
filter, where each region the filter covers is replaced by its max value within the region [68]. A 
pictorial illustration of a max-pooling layer is in Fig. 2.11. 
 
Figure 2.11.  A pictorial illustration of a max-pooling layer with a filter size of 2x2 and stride of 2. 
2.5.1.2.7 Summary 
 
The basic layers and the backpropagation algorithm discussed above cover the most 
essential components in a modern CNN for object detection, which is the most relevant to our goal 
of modeling the defect detection task in a model observer (the surrogate of a human observer). In 
the next section, we will review two recently published works that use CNN to model human 
observer in performing defect detection tasks with CT images.  
 
2.5.2 Review of CNN-based model observer 
 
Recent developments in deep learning have opened up a door to new opportunities in the 
field of task-based image quality assessment. Several recent studies have explored the use of CNNs 
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as model observers. In [69] and [70], the authors demonstrated good agreement between CNN-
based model observers and human observers on single-slice 2D detection tasks in both simulated 
and clinical mammography but concluded that a large amount of training data is needed. In 
[71], CNN-based model observers achieved similar performance to human observers on a uniform 
background in CT phantom images. In a more recent work [72], a CNN was trained to approximate 
the ideal observer, using a computer-simulated uniform background with correlated noise.  
Although these above-mentioned studies demonstrated good agreement between CNN-
based model observers and human observers, those observers were not designed to reproduce 
human observer task performance. To model human observer task performance, a calibration 
process is often needed to model inter- and intra-variability of the human [56]. Intra-observer 
variability refers to the fact a human observer will produce, in general, in different rating values 
in different reading trials. Inter-observer variability refers the variation in rating values for the 
same image read by different human observers. Only recently have CNN model observers been 
proposed to model human observer performance on 2D defect detection tasks.  
In [71], an MLP and a CNN were proposed to predict the performance of a human observer 
on a liver lesion detection task using single-slice, single-orientation CT images and were compared 
to a CHO (with Gabor channels and internal channel noise). The MLP consisted of an input layer 
and an output layer with a nonlinear activation (SoftMax) function. A 2D image was vectorized 
and fed as input to the MLP and the SoftMax function normalized the output values of all units (𝑘 
= 1, …, 𝐾; human observer’s rating value ranging from 1 to 𝐾) of the output layer and returns the 
likelihood that the image is of class 𝑘.  The CNN was composed of two convolutional layers, each 
followed by a max-pooling layer and a flattening layer followed by two fully connected layers 
with the last one having an output size 1 × 𝐾. The human observer rating values were used to train 
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the MLP and CNN. The results of the work showed that the MLP and CNN correlated well (very 
close to the performance of the CHO with internal noise) with the results from a human observer 
for different x-ray exposure levels (multiple models were trained) and lesion sizes. However, the 
authors pointed out that they had a relatively large amount of training data for the MLP-based 
model observer and also their results were generated on a relatively simple task using CT phantom 
images with a uniform background. Thus, further evaluation on more challenging and realistic 
tasks is needed. 
More recently, a deep-learning-based model observer (DL-MO) was proposed to model 
human observer performance on a lung nodule detection and localization task on multi-slice, 
single-orientation 2D CT images [73]. The work was based on an underlying assumption that there 
exists similarity between the CNN and the human visual system. So, they proposed to use a pre-
trained CNN (trained using natural images) as a deep feature extractor as an initial stage applied 
to the input image. In order to reduce the dimension of the feature map, the extracted feature maps 
(from a pre-selected layer) were subsequently fed to a feature-engineering model to generate the 
test statistic for an input image. Specifically, their proposed framework included four major 
components: a pretrained CNN, a partial least square regression discriminant analysis (PLS-DA) 
model, an internal noise component, and a nodule searching process. A sliding window strategy 
was first used on the input image (single-orientation 2D slices) to extract local image patches that 
were used as the inputs to a pretrained CNN (ResNet50 [74]). The CNN was pretrained on a natural 
image dataset, and the output from an intermediate layer (pre-selected) of the CNN was used as 
input to the PLS-DA model to generate a test statistic, 𝜆0, for the input image patch. A spatial 
distribution of the test statistics (heat map) was obtained by scanning through all potential nodule 
locations. The nodule search process was then applied to identify the location of the voxel in the 
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original input image that coincided with the maximal value of the test statistic in the heat map, i.e., 
the most-likely location of lung nodules. Finally, an internal noise component was added to the 
maximal test statistic to model the variation of human reader performance, i.e., 𝜆 = 𝜆0 +
𝛼𝑁(0, 𝜆0,𝑏𝑘𝑔), where 𝜆 denotes the final test statistic and 𝛼 is the weighting factor that is to be 
found out in the calibration process. The work demonstrated strong correlation and agreement 
between the proposed DL-MO and human observers for a low-contrast liver lesion detection task 
in patient liver background. However, the author stated that one of the limitations of the work is 
that there are two free parameters (the CNN layer used for feature extraction and the number of 
PLS components) that need to be properly determined to achieve reasonable performance for this 
method. 
In summary, the CNN-based model observer seems to have a promising use in the 
optimization of medical imaging systems and acquisition methods. However, the biggest 
limitations for the current observer models, which include both the CNN-based models and the 
traditional models, is the inability to handle 3D data in a rigorous way, or more specifically, to 
model the human scanning-and-confirming process in a faithful way. Most of those model 
observers were designed for analyzing single-orientation 2D slices. By contrast, many clinical 
tasks require the interpretation of 3D datasets, which requires the reader to scan and confirm 
defect(s) using multiple slices in multiple orientations. Thus, it remains a challenge to fully model 





Chapter 3 A projection image database to investigate factors affecting 
image quality in weight-based dosing: application to 
pediatric renal SPECT 
A projection image database to investigate factors 
affecting image quality in weight-based dosing: 




In nuclear medicine imaging, the product of acquisition duration and administered activity 
(AA) determines the level of quantum noise present in the image. Quantum noise can have a direct 
impact on diagnostic image quality, and, for the purposes of maximizing image quality, reducing 
AA, or reducing acquisition duration, it is desirable to study the relationship between these factors.  
Over the past decade, there has been an increased interest in reducing patient radiation 
exposure in diagnostic imaging studies that use ionizing radiation. Therefore, there has been 
significant interest in the nuclear medicine community in establishing universally accepted and 
optimized dosing guidelines for pediatric nuclear medicine studies. The European Association of 
Nuclear Medicine (EANM) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) 
have, respectively, published the European pediatric dosage card and the North American 
consensus guidelines for pediatric AA [12, 13]. The goal of these guidelines is to provide a balance 
between radiation risk and image quality. However, these guidelines were developed either based 
on a consensus of best practices or a simple estimate of image quality and not on a rigorous 
evaluation of diagnostic image quality relative to AA. 
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A second concern in pediatric imaging is the acquisition duration. Sedation is often 
required, especially for longer acquisitions. Longer acquisition durations increase the chance of 
patient motion, which can degrade image quality. Shorter acquisition durations are thus desirable. 
All else being equal, reducing the product of AA times acquisition duration will increase the 
Poisson noise in the image. However, the effect of changes in quantum image noise on diagnostic 
performance are complicated [47]. Similarly, decreasing quantum noise in the images requires 
increasing AA, acquisition duration, or both. Increasing the AA above that needed to provide 
acceptable image quality violates the principle of as low exposure as reasonably possible 
(ALARA). Consequently, appropriate guidelines for pediatric AAs are of significant interest [75]. 
Similarly, increasing the acquisition duration in pediatric patients to compensate for reduced AA 
may not be acceptable. Thus, understanding the tradeoff between image quality and the product of 
AA and acquisition duration is an important problem. 
In 2008, the Dosimetry and Pediatrics Committees of the EANM published the first version 
of the EANM pediatric dosage card to better standardize the AAs in pediatric nuclear medicine 
procedures. The dosage card was based on data from a publication by Jacobs et al. [76]. In that 
study, count rates and effective doses were computed as a function of body weight for 10 
radionuclides and 95 radiopharmaceuticals, respectively, using 7 hermaphrodite anthropomorphic 
computational phantoms [77]. Count rate was used as the only surrogate for image quality; a 
discussion of the details and limitations of that aspect of that work are provided in the discussion 
section. 
A second effort at standardization of pediatric dosages was the 2010 North America 
Consensus Pediatric Dosing Guidelines [78]. The AAs recommended in that report were slightly 
lower for infants and small children as compared to the EANM guidelines, compensating for the 
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higher radiation risk in early childhood. Those guidelines were based on a combination of 
experience and retrospective analysis of clinical data, taking into account the patient’s weight and 
count rate density per unit area or volume, and using these as the surrogates for radiation risk and 
count rates as the surrogate for image quality.  
In 2011, Sgouros et al. proposed a rigorous method to balance diagnostic image quality 
with cancer risk using 99mTc-DSMA as an example [5]. The study showed that weight alone may 
not be sufficient for optimally scaling AA in children. In that study, nonuniform rational B-spline 
(NURBS)-based anatomic phantoms, realistic organ uptakes and models of the image formation 
process, and task-based measures of image quality were used to objectively compare image quality 
of 99mTc-DMSA SPECT images. Two 10-year-old females of the same weight but different 
heights, respectively representing short-stout and tall-thin patients, were used in that study. Several 
different AAs (25%, 50%, 75%, 100%, 125%, and 150%), defect locations, and lesion severities 
with different target-to-background activity concentration ratios were simulated to represent 
clinical imaging. Channelized Hoteling observer methodology was used in a receiver-operating-
characteristic (ROC) analysis of lesion detectability to study the relationship between AA and the 
area under the ROC curve (AUC). The results of the study showed that the same AUC could be 
obtained for the tall-thin phantom with approximately half the AA as for the short-stout phantom. 
[5].  
In this present study, we have built upon the Sgouros et al. work by developing a realistic 
pediatric phantom population including variations in age, gender, kidney size, and height. We have 
also proposed a novel method that produces contrast-matched, clinically-relevant defects in all of 
the phantoms across different ages, gender, body morphometries, and kidney sizes. The 
combination of these methods allows application of task-based image quality methods to 
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rigorously assess current dosing guidelines in terms of their effectiveness for equalizing image 
quality across patients with different age and body morphometry.  
Toward this end, we simulated realistic projections of the pediatric patient population in 
preparation for future detailed investigations of the tradeoffs between image quality, the product 
of AA and acquisition duration, patient weight and height, and reconstruction method for 99mTc-
DMSA renal imaging. Using this realistic phantom population and projection database, we 
investigated the effects of scatter, count density, and radius of rotation as a function of patient 
morphometry. These studies provide insight into the changes in these surrogate indices for factors 
affecting image quality and how they change with patient weight and body morphometry and the 
limitations of weight-based scaling of AA. We also performed a model observer study to 
investigate further the impact of patient weight on image quality to study the validity of weight-
based dose scaling for 99mTc- DMSA imaging. 
3.2 Methods 
 
3.2.1 Population of realistic digital phantoms 
 
The database of projection data for this study was generated using the Advanced 
Laboratory for Radiation Dosimetry Studies (ALRADS) UF NHANES-based phantom series [79]. 
The phantom population realistically models pediatric heights, weights, organ sizes and anatomies 
for both genders at five ages. The phantoms were adjusted to model variations in height and organ 
size prior to voxelization. The ages modeled were newborn, 1-, 5-, 10-, and 15-years old. For each 
age, we modeled the 50th percentile weight and 10th, 50th, and 90th percentile heights, simulating 
patients having the average weight at each age with varying body habitus. The 10th, 50th and 90th 
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height percentile phantoms are referred to as short-stout, reference, and tall-thin patients, 
respectively 
 
Figure 3.1.  Sample coronal slices of the body reminder, cortex, medulla, pelvis, liver and spleen (from left to right) 
of a newborn 50th height percentile male phantom. 
 
For each age and height percentile, we modeled three kidney masses: -15%, average, and 
+15%, where average is the International Commission on Radiological Protection (ICRP) standard 
mass for a patient with the corresponding age and the percentiles are the change relative to this 
standard mass. The variations in kidney mass model variations in patient kidney size; for newborn 
patients, the dosimetric impact of these sizes on risk has been previously studied [79].  
In addition to anatomic variability, we simulated variations in uptake in 6 tissues: cortex, 
medulla, pelvis, spleen, liver, and body reminder (the remaining soft tissues of the phantom). Fig. 
3.1 shows sample coronal slices of these different objects (organs and renal sub-structures) in a 
newborn phantom of average height (50th percentile height). Projections of each object were 
generated separately assuming a uniform activity distribution. The individual projections could 
then be scaled and summed to represent the count level that would be obtained in projections for 
an arbitrary AA, acquisition duration, or set of relative uptakes. By individually generating and 
scaling these projections, we were able to adjust the uptakes in each individual object to simulate 
uptake variability.   
Each phantom was digitized prior to simulation into 0.1 cm cubic voxels and truncated in 
the axial direction to exclude regions more than 5 cm below the bottom or above the top of the 





3.2.2 Organ uptake model 
 
Uptake in the kidneys was estimated using data from a single imaging time point, which 
varied slightly across patients, from datasets of 47 patients with ages ranging from 1 to 16 years 
acquired at the Boston Children’s Hospital (BCH). We did not attempt to develop an age-specific 
pharmacokinetics model from this data, and considered the data from all patients as a single mixed-
age population sample for estimating uptake of activities in the kidneys. CT scans of these patients 
were not available for attenuation compensation as they were not acquired as part of the patient’s 
clinical study. Instead, attenuation maps were estimated based on automated intensity thresholding 
of images reconstructed from scatter windows. The data were reconstructed using 5 iterations with 
8 subsets per iteration of an ordered-subsets expectation-maximization (OS-EM) reconstruction 
method that included attenuation, scatter and collimator-detector response compensation. 
Reconstructed images were converted to units of activity concentration using the measured camera 
sensitivity. The kidneys were segmented automatically using intensity thresholding, and the 
reasonability of the kidney VOIs and body contours were reviewed manually. The percent of the 
decay-corrected AA in the kidneys in these VOIs is referred to as the kidney uptake fraction. In 
addition, we used thresholding to segment the kidney cortex and pelvis/medulla regions. From 
these we computed the ratio of activity concentrations (sum of activity values divided by volume 
of the VOI) in the cortex to the medulla/pelvis. This ratio is referred to as the cortex-to-medulla 
plus pelvis activity concentration ratio. The results obtained from the above procedure are 




The fractional uptakes in the spleen and liver at the imaging time were obtained from Evans 
et al. [80]; the values used were  4.3% and 1.7%, respectively. We validated these percentages 
against the real patient data from BCH and found that the uptake variations for these organs were 
small across the patient datasets and small compared to the uptake in the kidneys. Therefore, we 
used constant uptake percentages for liver and spleen in the simulations. 
To model the differences in uptake of the fine structures inside the kidney (renal cortex, 
medulla, and pelvis), we quantified the relative uptakes inside these renal structures using the data 
from the aforementioned 47 patient images. The relative uptake values were estimated using the 
reconstructed images described above. We used threshold-based segmentation to separate the 
cortex from the medulla plus pelvis and created two separate VOIs for the two entities. These VOIs 
and the activity values inside them were used to estimate activity concentration of each entity.  The 
mean and standard deviation of the cortex-to-medulla plus pelvis activity concentration ratios were 
calculated and are summarized in Table 3.1. 
The resolution in the images was not sufficient to estimate accurately the activity 
concentration ratio between medulla and pelvis. Thus, we based the activity concentration ratio in 
these two structures on input from our clinical collaborators. Images were generated with a variety 
of concentration ratios; images having a medulla-to-pelvis concentration ratio of 1:1 were deemed 
most realistic, and that ratio was thus used in the study.  
 
3.2.3 Organ uptake variations 
 
We modeled random variations in the uptake of the kidneys as a whole and in the cortex 
relative to the medulla plus pelvis using truncated Normal distributions. The values of the 
minimum, maximum, mean and standard deviation of these distributions were obtained from the 
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47 patients described above, and are given in Table 1. For each phantom anatomy, we randomly 
sampled 384 values each of the fraction of injected activity in the entire kidney and the cortex-to-
medulla plus pelvis activity concentration ratio. From these data combinations, the weight-based 
AA, and the kidney volume, we calculated the activity concentrations in the cortex, medulla and 
pelvis for each of the 384 uptake realizations. 
3.2.4 Projection data simulation 
 
The projections were simulated using an analytic projection code that models attenuation, 
spatially varying detector-to-collimator response [81], and object-dependent scatter [82]. This 
code has been extensively validated for imaging of a variety of radionuclides by comparison to 
Monte Carlo simulations and experimental projection measurements. We modeled a low-energy, 
ultra high-resolution (LEUHR) collimator, a 360° body-contouring orbit, 120 projection views, a 
15% wide energy window centered at 140 keV, an energy resolution of 9% at 140 keV, and a 0.1 
cm projection bin size. After each simulation, the projections were collapsed isotropically by a 
factor of 2 to simulate a 0.2 cm projection bin size. Attenuation maps used in the projection 
operation were constructed by assigning the attenuation coefficient of the organ in the phantom 
containing the voxel center to the entire voxel.  The attenuation coefficients were evaluated at 140 
keV for the material composition of each organ based on ICRP organ composition data [83]. Fig. 
3.2 shows sample transaxial images of attenuation distributions that illustrate variations in body 





Figure 3.2.  Sample transaxial images of the attenuation distribution for the (left to right) 10th, 50th, and 90th 
height percentile versions of the male phantom for ages (top to bottom) 0 (newborn), 1, 5, 10, and 15 years showing 









Figure 3.3.   Noise-free projection images of the kidney cortex, medulla, spleen, liver, pelvis, and body remainder 
for a male, reference-height, newborn phantom.  
 









Maximum 0.393 2.00 
Minimum 0.329 1.36 
Sample mean 0.361 1.68 
Sample standard deviation 0.025 0.25 
 
Projections were generated using the above methods individually for the kidney cortex, 
medulla, pelvis, liver, spleen, and the body reminder, by assigning unit intensity to the phantom 
voxels in each of these regions. The organ projections were then scaled by the randomly-sampled 
uptake scaling factors needed to obtain the desired activity concentrations. They were then 
summed and scaled by the camera sensitivity to obtain the raw projections per unit injected activity 
per acquisition duration. These raw projections were next scaled by the acquisition duration and 
desired AA to give the mean projections in units of counts. Using these as input to a Poisson 




3.2.5 Simulated projection data with variation in injected activity 
 
Six count levels were simulated: 25%, 50%, 75%, 100%, 125%, and 150%. Here, a count-
level indicates the fraction of AA relative to the AA obtained from the 2010 North American 
Consensus Dosing Guidelines. Note that the suggested minimum and maximum AAs in these 
guidelines were only enforced for the clinical (100%) count level. Fig. 3.3 and 3.4 show a sample 
set of noise-free projections of the organs for the newborn and sample noisy projection images 
from the various count levels.  
 
 
Figure 3.4.   Sample noisy posterior projection images from the various count levels.  From top to bottom, 
shows kidneys for the 0, 1, 5, 10, and 15-year-old phantoms. From left to right, the simulated count levels 
were 25%, 50%, 75%, 100%, 125%, and 150% of those of the 2010 North American Consensus Dosing 
Guidelines.  
 













1 1.2 328821 373482 -12.718 
5 5 543850 540371 0.642 
10 9 831381 711803 15.498 
15   16 1100752 1215463 -9.905 




3.2.6 Validation of simulated projection image 
 
To validate simulation process, we chose patient images from each of the five ages. The 
patient and simulated projections were reconstructed using 2 iterations of 8 subsets of the OS-EM 
iterative reconstruction with detector-to-collimator response compensation only, followed by 
filtering with a 5-mm FWHM Gaussian filter. Sample reconstructed image slices are shown in Fig. 
3.5. Note that the kidney model in the phantom does not model the detailed structure of the medulla 
and pelvis. We computed the total of the reconstructed voxel values in volumes of images 
containing the kidneys. Table 3.2 shows a comparison of the counts in the simulated and patient 
images for the various ages.  
 
 
Figure 3.5.   From left to right, the top row shows patient images from 1.2, 5, 9, and 16-year-olds reconstructed 
using 2 iterations of 8 subsets of the OS-EM reconstruction with detector response compensation followed by a 
Gaussian filter with a FWHM of 0.5mm. The bottom row shows simulated images from 1, 5, 10, and 15-year-olds 
reconstructed using the same methods. 
 
 
3.2.7 Defect model 
 
Assessing image quality should be done with respect to the task that will be performed with 
the images. In the case of DMSA SPECT, the task is to detect functional defects in the renal cortex. 
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Thus, it is necessary to create defects in the simulated images. Since the ultimate goal of the project 
is to provide guidance data for selecting minimum AAs commensurate with detecting clinically 
relevant defects, we developed defects for each age that were challenging but clinically relevant 
[84]. Challenging defects will tend to be ones that are small, where partial volume effects produce 
low contrast defects in the reconstructed images. Since the distance from the collimator face to the 
kidney depends on patient size, resolution will tend to be worse for large patients compared to 
small ones. In addition, since the thickness of the cortex tends to be greater for larger patients, and 
partial volume effects depend on the uptake in tissues surrounding the defect that are within 
approximately two times the full width at half maximum (FWHM), the same physical defect size 
would be harder to visualize in a large patient than in a smaller patient. Also, when the kidney is 
larger, the same size defect would tend to be of less consequence in terms of total renal function. 
Thus, we chose to create defects with sizes that varied depending on the patient size. 
Based on input from an experienced pediatric nuclear medicine specialist (S.T. Treves), 
we selected a defect volume of 0.3 cm3 as the defect size that is clinically relevant and challenging 
for a newborn. To create a realistic defect, we used an ellipsoid with one major axis length equal 
to approximately the thickness of the cortex. The center of the ellipsoid was positioned along the 
line extending through the center-of-mass of the cortex at the point where it intersects the outer 
cortical surface. The half-length of the axis of the ellipsoid in this direction was equal to the cortical 
thickness along this line, meaning that the apex of the ellipse was at the inner surface of the cortex. 
The half-lengths of the other two axes were the same; for the newborn, the length of these 
remaining axes was set so that the intersection with the kidney cortex had a volume of 0.3 cm3. 
This was verified numerically by creating a voxelized version of the defect where the voxel values 
were set to unity using sub-voxel sampling by a factor of 2, taking the product of this ellipsoid 
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with the cortical VOI, and summing the values in the resulting product image. A trans-cortical 
defect with a realistic shape can be created by scaling the defect image by the desired contrast and 
subtracting this from the cortical VOI. Note that, due to the linearity of the projection operation, 
the subtraction can be performed in either the image or projection domain. The position along the 
cortex was defined by an angular coordinate in the coronal slice containing the defect center of 
mass. Gradual transitions of function can be modeled by blurring the ellipsoid with a Gaussian 
kernel prior to the multiplication described above. Sample images containing defects for phantoms 
representing various ages in Fig. 3.6. 
 
  
Figure 3.6.   Sample lower pole defects in noise-free reconstructed images for newborn, 1-, 5-, 10-, and 
15-year-old male phantoms with reference heights in coronal and sagittal views. The defect volumes for ages 




Figure 3.7.   Sample reconstructed images from noisy projection data using FBP reconstruction followed 
by a post-reconstruction 3D Butterworth filter with an order of eight and cutoff frequency of 0.12 cycle/pixel. 
Negative values were mapped to zero in the display. From left to right, the bottom and top rows shows coronal 
images with and without, respectively, a (lower pole) defect for the newborn, 1-, 5-, 10-, and 15-year-old 
male phantoms at the 50th height percentile. The volumes of these defects were chosen to be near the limits 




3.2.8 Reconstruction and post-reconstruction processing 
 
SPECT images were reconstructed from the simulated projections using filtered 
backprojection (FBP) reconstruction and a ramp filter with no apodization. The reconstructed 
images had cubic voxels with a side length of 0.2 cm. The reconstructed images were post-filtered 
with 3-D Butterworth filters of order 8 and cutoff frequency 0.12 cycles/pixel. Fig. 3.7 shows a 
sample set of reconstructed images for the five ages.  
 
3.2.9 Quantitative measures of image quality 
 
Defect detectability depends, in principle and among other factors, on the contrast of the 
defect and the amount of noise in the reconstructed image. The contrast of the defect depends on 
the intrinsic contrast of the defect relative to surrounding tissues and the size of the defect with 
respect to the resolution of the imaging system. In addition, contrast is degraded by the effects of 
scattered photons from surrounding tissues. In the following we present physical measures of 
image quality that quantify the noise, image resolution, and scatter, all of which together affect 
image quality.  
We measured the contribution of scattered photons in the kidney region by the scatter-to-
primary ratio obtained from projection images that only contain the kidneys. The images of the 
kidneys resulting from detected scattered photons were obtained by subtracting the kidney 
projection generated with attenuation, collimator-to-detector response, and scatter from the same 
projection generated with attenuation and collimator-to-detector response. The numbers of 




Lastly, we quantified the noise in the kidney region by the kidney count density, i.e., the 
number of detected primary photons emitted in the kidneys divided by the kidney volume. We 
used the primary-photon-only projection images of the kidneys, generated as described above, for 
this calculation. We performed this calculation for all 90 phantoms using the same mean kidney 
uptake fraction (0.361) and cortex-to-medulla plus pelvis activity concentration ratio (1.68) in all 
cases. The count density was averaged over the 3 kidney sizes for each phantom. 
In SPECT, the image resolution at the center of rotation is proportional to the radius of 
rotation. Thus, we quantified the system resolution by the distance from the collimator face to the 
center of rotation averaged over the (body contouring) camera orbit. Note that the phantoms were 
placed on a camera bed measured using a CT scan, so the camera orbit, especially for the small 
phantoms, was constrained in some views by the size of the bed.  
 
3.2.10 Model observer study 
 
The model observer study was performed using methods similar to those previously 
described in [5]. In summary, seven 2-dimensional frequency-domain bandpass difference-of-
mesa channels were used to approximately model the human visual system. The starting frequency 
and width of the first channel was 0.5 cycles per pixel, and subsequent channels had widths that 
doubled and abutted the previous channel. These channels were applied to the 3 orthogonal slices 
(transaxial, sagittal, and coronal) that contained the defect centroid.  The output of this procedure 
was a 21-element feature vector.  
In previous work, feature vectors were analyzed using a Hotelling Observer (HO) 
methodology, a combination often referred to as the channelized Hoteling observer (CHO). 
However, the projections in the database and resulting reconstructed images reflect variations in 
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anatomy and uptake. This resulted in features vectors that were often multi-modal thus not 
multivariate normally (MVN) distributed. We have previously demonstrated that this can result in 
difficulty for the HO [85]. Thus, instead of traditional CHO, we used a multi-template strategy 
proposed by Li and Jha [86] to handle the non-MVN data. In this strategy, the entire ensemble of 
input data vectors is decomposed into sub-ensembles that are approximately MVN. A linear 
discriminant trained using the data for that sub-ensemble is then used to analyze the set of feature 
vectors for that sub-ensemble. The set of test statistics from each sub-ensemble is then pooled and 
analyzed using ROC analysis. In this work, the channel output vectors were sorted into sub-
ensembles based on defect location, age, and height percentile. It was verified qualitatively that 
the resulting channel output data were not multi-modal and were nearly MVN distributed. We used 
a leave-one-out sampling methodology to generate the subsets for each sub-ensemble [87]. We 
pooled the test statistics for each defect location and height percentile and applied ROC analysis. 




3.3.1 Quantification of noise by renal count density 
 
Figure 3.8 shows plots of the average kidney count density as a function of patient age for 
the different height percentiles for male and female phantoms, respectively. Overall, the plots 
demonstrate that the weight-based AA produced nearly equal kidney count densities for all ages 
except for the newborn. The data also shows that gender did not affect count density in patients 
less than 10 years old. This indicates that there is not much difference in the overall attenuation in 
the kidney region between the male and female phantoms for these ages. Note that, in theory, we 
 
 59 
expect to see rankings of the values of the count density in the order 90th > 50th > 10th height 
percentile: we would expect the short-stout phantoms to allow fewer photons to escape the body 
than for the reference or the tall-thin phantoms. However, this was not observed in all cases. For 
example, we see that, for the 10-year-olds, the largest difference was between the 10th and 50th 
height percentile. This difference in count density was approximately 30% in the male phantoms 
and 15% in the female phantoms. For the 15-year-olds, the differences were 25% for the male 
phantom and 15% for the female phantoms, respectively. There was essentially no difference in 
count density between 10th and 90th height percentile phantoms for both the 10 and 15-year-olds 
for both genders.  
Fig. 3.9 shows transaxial images of phantom slices at the mid-kidney level for the 10th, 
50th, and 90th height percentile from male phantoms with ages 0, 1, 5, 10, and 15. From these 
images, we can see that there was not a significant difference in body circumference (girth) among 
phantoms for different heights nor a strong correlation between girth and phantom height rankings. 
That is, the 10th height percentile (short-stout) phantom did not necessarily have a larger girth than 
the 90th height percentile (tall-thin) phantom or the reference phantom, at the mid-kidney level. 
These images provide a pictorial illustration of the reason that the observed count density did not 
vary as expected with patient height. 
 
Figure 3.8.  Average kidney count density obtained for three different height percentiles as a function of phantom age for male 







Figure 3.9.  Sample transaxial phantom images at mid-kidney level in 10th, 50th, and 90th height 
percentile (from left to right) from the male phantom of age 0, 1, 5, 10, and 15 (from top to bottom) 




3.3.2 Quantification of scatter by scatter-to-primary ratio 
 
Fig. 3.10 shows plots of the average scatter-to-primary ratio for the three different height 
percentiles as a function of patient age for male and female phantoms, respectively. It is clear that 
dosing by weight did not equalize the effects of scatter. These data also demonstrate that the 
scatter-to-primary ratios depended to a varying degree on height. Just as for count density, the 
expected rankings were not consistently observed. For example, one would expect the tall-thin 
patient to have a smaller scatter-to-primary ratio than the short-stout phantom. However, this was 
not observed for the 15-year-old male, though the differences in the ratios for the different heights 
were generally small. In any event, these data suggest that weight and height alone may not 
sufficient for predicting the effects of scatter, and thus their degrading effects on image quality.  
 
 
Figure 3.10.  Average scatter-to-primary ratio obtained from three different height percentiles as a 
function of phantom age for male and female. 
 
3.3.3 Quantification of resolution by camera radius of rotation 
 
Fig. 3.11 shows plots of the average camera radius of rotation for the three different height 
percentiles as a function of patient age for male and female phantoms, respectively. Again, the 
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expected trend, larger height percentiles having smaller average radii of rotations, was not always 
observed. The cause is likely for the same reason that differences in count density did not vary as 
expected with height: the maximum girth of the patient, which determines the distance from the 
camera to the body for a body contouring orbit, did not vary directly with height percentile. This 
indicates that height and weight are not sufficient to predict resolution effects. This is especially 
true for the small phantoms as the radius of rotation was limited by the size of the imaging bed in 
the lateral direction. 
 
Figure 3.11.  Average camera radius of rotation obtained from three different height percentiles as a function of 
phantom age for male and female.              
 
 
Figure 3.12.  Image quality result on a defect detection task for the 1- and 5-year-old phantoms. A 20% defect 




3.3.4 Model observer study results 
 
Fig. 3.12 shows plot of AUC as function of the product of percent AA and acquisition 
duration for the 1- and 15-year-old on a defect detection task. Image quality was studied as a 
function of count level using the developed database with a fixed acquisition duration of 960 
seconds. The saturation of the AUC values indicates that there is a decreasing benefit of increasing 
the AA, indicating that detection is limited by background variation. These results show that there 
was a monotonic but modestly saturating increase in AUC with AA. The fact that there was modest 
saturation indicates that image quality was limited by quantum noise and the effects of object 
variability were modest [88]. More importantly, the results show that the AUCs for an AA of 100% 
of the weight-based, consensus dosing guideline were not equal, indicating that the ability to detect 
a defect with the same contrast, was not the same for the AA recommended by the North American 
Consensus Guidelines. This, combined with the results of the other image quality surrogates 
reflecting noise, scatter, and resolution effects, suggest that weight-based scaling is not sufficient 




This paper describes the design and simulation of a realistic projection database for use in 
pediatric renal SPECT research. The population included variability in age (and thus weight), 
gender, kidney size, and height. The specific dataset generated here was focused on matching the 
defect detectability across the population for a challenging and relevant defect detection task. We 
thus designed a set of defects, one for each phantom and kidney size, that is clinically relevant but 
at the limits of what is likely to be detectable. Thus, the curve describing the tradeoff between 
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image quality and AA is for a difficult case; larger defects are likely to be easier to detect and thus 
not as affected by reductions in AA.  
Using the established projection database, we investigated the AAs based on the current 
North American consensus weight-based dosing guidelines in terms of impact on surrogates for 
factors that affect image quality (image noise, resolution, and contrast). As compared to the 
approach by Jacobs et al. [76], the present study provides a more rigorous evaluation on image 
quality by adopting a more realistic phantom database, imaging simulations, pharmacokinetic 
model, and task-based image quality evaluation method. In the Jacob et al. study, 7 phantoms were 
used, representing newborns and children (male only) of 1, 5, 10, and 15 years, adult females and 
adult males, corresponding to their reference weights. Though these phantoms included 7 organs, 
the radionuclide was assumed uniformly distributed in the phantom (no inter-organ uptake 
variability) for the purposes of estimating count rates. The fraction of energy absorbed by the target 
organs at the emitted photon energy was computed using Monte Carlo simulations. The count rates 
that would be obtained with gamma camera imaging were assumed to be proportional to the 
average number of photons (at energies useful for imaging) that exited the body. These count rates 
were considered to have potentially contributed to the image. The fraction of exiting photons was 
computed as a weighted sum of the non-absorbed fractions (one minus the absorbed fraction) at 
the energy of each emitted photon. The average number of photons emitted per disintegration for 
each emitted photon energy was used to weight the absorbed fractions, and only emitted photon 
with abundances greater than or equal to 10% and energies suitable for imaging were included in 
the calculation. Normalization factors for the count rates were obtained by dividing corresponding 
count rates by that for an adult male of 70 kg (normalization factor = 1.0).  
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Using the count rates estimated by this method as the sole surrogate for image quality has 
several limitations. First, it ignores the effects of other factors, such as scatter and resolution, which 
can vary with body size. Related to this, energy exiting the body is an incomplete surrogate for 
primary photon counts. It equates, for example, two or more scattered photons with total energy 
equal to the primary photon energy to a primary photon. In other words, the use of total energy as 
a surrogate for primary photon counts is valid if the scatter-to-primary photon fraction is a constant 
across the entire patient population. However, this is not the case as was demonstrated above. 
Second, the method assumed uniform radionuclide distribution in the body. This is less than ideal, 
especially for agents such as DMSA that concentrates in a small number of tissues. Third, there 
was no variation in organ size or patient height for a given weight. Finally, the suggested minimum 
AAs were purely based on effective dose and not image quality. The authors did point out in the 
discussion that the suggested AAs calculated using this method could possibly lead to impractical 




A realistic projection database has been generated for investigation of relationship between 
image quality and patient morphometry in 99mTc-DMSA renal SPECT. A total of 207,360 
projection images was generated, encompassing 6 different administrated activities for 90 phantom 
anatomies. This projection database can be used to study the relationship between the product of 
AA and acquisition duration and image quality in a way that is impossible with either real patients 
or via experimental phantoms. The database generated in this work is immediately applicable to 
other pharmaceuticals labeled with 99mTc used in pediatric imaging such as 99mTc-MAG3 or 99mTc-
MDP; only scaling and summing of the organ projections with appropriately scaling factors 
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reflecting agent biokinetics. Further, the methods used in this study are applicable to studying these 
tradeoffs for other diagnostic and/or therapeutic radiopharmaceuticals in both pediatric and adult 
patients.  
Using this projection database, we conducted a quantitative analysis of three factors that 
affect image quality: noise, as measured by kidney count density; scatter, as measured by the 
scatter-to-primary ratio for photons emitted from the kidneys; and resolution, as measured by the 
average radius of rotation. The results of this study showed that weight-based dosing was partially 
able to offset losses in count density due to variations in patient weight. However, it suggested that 
the kidney count density for newborns was higher than for other ages using weight-based dosing. 
The results also demonstrated variations in scatter and resolution that depend on body 
morphometry, but were not well correlated with phantom height. We also performed a task-based 
image quality study using an anthropomorphic model observer that demonstrated that the weight-
based scaling of the AA did not equalize image quality as measured by the AUC. This, combined 
with the image quality surrogate data on noise, scatter, and resolution, suggests that weight-based 
scaling is not sufficient, suggesting that a dosing procedure beyond simple weight-based scaling 
of AA is required to equalize image quality in pediatric renal SPECT. Further, the results also 
suggest the need for more detailed task-based studies of image quality, and that variables beyond 
height and weight are needed in order to prescribe AAs that optimize image quality in order to 








Chapter 4  Current pediatric dosing guidelines for 99mTc-DMSA SPECT 
based on patient weight do not provide the same task-
based image quality 
Current pediatric dosing guidelines for 99mTc-DMSA 
SPECT based on patient weight do not provide the 




In nuclear medicine imaging, the product of acquisition duration and administered activity 
(AA) determines the level of quantum noise present in the image. Quantum noise can have a direct 
impact on diagnostic image quality, and, for the purposes of maximizing image quality, reducing 
AA, or reducing acquisition duration, it is desirable to study the relationship between these factors.  
Over the past decade, there has been an increased interest in reducing patient radiation 
exposure in diagnostic imaging studies that use ionizing radiation. Therefore, there has been 
significant interest in the nuclear medicine community in establishing universally accepted and 
optimized dosing guidelines for pediatric nuclear medicine studies. The European Association of 
Nuclear Medicine (EANM) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) 
have, respectively, published the European pediatric dosage card and the North American 
consensus guidelines for pediatric AA [12, 13]. The goal of these guidelines is to provide a balance 
between radiation risk and image quality. However, these guidelines were developed either based 
on a consensus of best practices or a simple estimate of image quality and not on a rigorous 
evaluation of diagnostic image quality relative to AA. 
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A second concern in pediatric imaging is the acquisition duration. Sedation is often 
required, especially for longer acquisitions. Longer acquisition durations increase the chance of 
patient motion, which can degrade image quality. Shorter acquisition durations are thus desirable. 
All else being equal, reducing the product of AA times acquisition duration will increase 
the Poisson noise in the image. However, the effect of changes in quantum image noise on 
diagnostic performance are complicated [47]. Similarly, decreasing quantum noise in the images 
requires increasing AA, acquisition duration, or both. Increasing the AA above that needed to 
provide acceptable image quality violates the principle of as low exposure as reasonably possible 
(ALARA). Consequently, appropriate guidelines for pediatric AAs are of significant interest [75]. 
Similarly, increasing the acquisition duration in pediatric patients to compensate for reduced AA 
may not be acceptable. Thus, understanding the tradeoff between image quality and the product of 
AA and acquisition duration is an important problem. 
In 2008, the Dosimetry and Pediatrics Committees of the EANM published the first version 
of the EANM pediatric dosage card to better standardize the AAs in pediatric nuclear medicine 
procedures. The dosage card was based on data from a publication by Jacobs et al. [76]. In that 
study, count rates and effective doses were computed as a function of body weight for 10 
radionuclides and 95 radiopharmaceuticals, respectively, using 7 hermaphrodite anthropomorphic 
computational phantoms [77]. Count rate was used as the only surrogate for image quality; a 
discussion of the details and limitations of that aspect of that work are provided in the discussion 
section. 
A second effort at standardization of pediatric dosages was the 2010 North America 
Consensus Pediatric Dosing Guidelines [78]. The AAs recommended in that report were slightly 
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lower for infants and small children as compared to the EANM guidelines, compensating for the 
higher radiation risk in early childhood. Those guidelines were based on a combination of 
experience and retrospective analysis of clinical data, taking into account the patient’s weight and 
count rate density per unit area or volume, and using these as the surrogates for radiation risk and 
count rates as the surrogate for image quality.  
In 2011, Sgouros et al. proposed a rigorous method to balance diagnostic image quality 
with cancer risk using 99mTc-DSMA as an example [5]. The study showed that weight alone may 
not be sufficient for optimally scaling AA in children. In that study, nonuniform rational B-spline 
(NURBS)-based anatomic phantoms, realistic organ uptakes and models of the image formation 
process, and task-based measures of image quality were used to objectively compare image quality 
of 99mTc-DMSA SPECT images. Two 10-year-old females of the same weight but different 
heights, respectively representing short-stout and tall-thin patients, were used in that study. Several 
different AAs (25%, 50%, 75%, 100%, 125%, and 150%), defect locations, and lesion severities 
with different target-to-background activity concentration ratios were simulated to represent 
clinical imaging. Channelized Hoteling observer methodology was used in a receiver-operating-
characteristic (ROC) analysis of lesion detectability to study the relationship between AA and the 
area under the ROC curve (AUC). The results of the study showed that the same AUC could be 
obtained for the tall-thin phantom with approximately half the AA as for the short-stout phantom. 
[5].  
In this present study, we have built upon the Sgouros et al. work by developing a realistic 
pediatric phantom population including variations in age, gender, kidney size, and height. We have 
also proposed a novel method that produces contrast-matched, clinically-relevant defects in all of 
the phantoms across different ages, gender, body morphometries, and kidney sizes. The 
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combination of these methods allows application of task-based image quality methods to 
rigorously assess current dosing guidelines in terms of their effectiveness for equalizing image 
quality across patients with different age and body morphometry.  
        Toward this end, we simulated realistic projections of the pediatric patient population in 
preparation for future detailed investigations of the tradeoffs between image quality, the product 
of AA and acquisition duration, patient weight and height, and reconstruction method for 99mTc-
DMSA renal imaging. Using this realistic phantom population and projection database, we 
investigated the effects of scatter, count density, and radius of rotation as a function of patient 
morphometry. These studies provide insight into the changes in these surrogate indices for factors 
affecting image quality and how they change with patient weight and body morphometry and the 
limitations of weight-based scaling of AA. We also performed a model observer study to 
investigate further the impact of patient weight on image quality to study the validity of weight-
based dose scaling for 99mTc- DMSA imaging. 
 
4.2 Methods and materials 
 
4.2.1 Series of realistic digital phantoms 
 
The series of pediatric phantoms used was developed at the University of Florida and was 
based on demographic data from the CDC’s National Health and Nutrition Examination Survey 
(NHANES) data [79]. It consisted of 90 phantoms that included variations in age, gender, height, 
and kidney mass. For each gender, five groups were modeled: 0, 1, 5, 10, and 15 years of age. All 
phantoms at a given age had a weight equal to the 50th percentile weight and one of three height 
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percentiles: 10th (short), 50th (reference) and 90th (tall). The phantoms for each height percentile 
and age group are shown in Fig. 4.1. The targeted weights for each age are provided in Table 4.1. 
For each height percentile, we modeled 3 kidney sizes: -15%, average, and +15%. The variation 
in kidney size was used to model the effects of anatomical variation [79] that would not be 




Figure 4.1.  Renderings of 10th, 50th, and 90th percentile height at constant 50th percentile weight newborn, 





Table 4.3. Summary of phantom masses 
Age (yr) Male Female 
Newborn 3.5 kg  3.4 kg 
1y 10.4 kg 9.5 kg 
5y 20 kg 20 kg 
10y 30 kg  35 kg 
15y 55 kg 50 kg 
 
4.2.2 Pharmacokinetics model 
 
A new pharmacokinetic (PK) model for 99mTc-DMSA was used in this study to model 
kidney uptake [89]. The PK model is based on literature data and was validated using 47 patient 
datasets acquired at the Boston Children’s Hospital (BCH). Tracer uptake in individual organs, i.e., 
the kidneys, spleen, liver, and body remainder, at 3 hours post injection was computed using the 
PK model. Variations in tracer uptake based on those seen in the 47 patient datasets were modeled 
using the coefficient of variation (percent standard deviation) from those data and assuming a 
truncated normal distribution. 
 
4.2.3 Defect model 
 
We used a defect model described in [84]. In the model, a defect volume of 0.3 cm3 for a 
newborn patient with the reference kidney size and 50th height percentile was deemed, by an 
experienced pediatric nuclear medicine specialist, clinically relevant and at the limits of clinical 
detectability in the newborn phantom. Defect volumes for other ages were determined so that the 
defect contrast for each age at the 50th height percentile was the same as for that phantom [84]. 
Using this model, focal renal lesions consisting of areas of reduced uptake were created to simulate 
focal acute pyelonephritis in three locations (lower pole, upper pole and lateral aspect of the kidney) 
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along the cortical wall.  
 
4.2.4 Projection data simulation 
 
For each phantom in the population, we simulated noise-free projection data for the renal 
cortex, medulla, pelvis, liver, spleen, and background (including all other organs), modeling the 
physics and acquisition parameters appropriate for 99mTc renal SPECT. The projections were 
generated using an analytic projection code that modeled attenuation, spatially varying collimator-
to-detector response [81], and object-dependent scatter [82]. The code has been previously 
validated by comparison to Monte Carlo and experimental projection data for imaging of a variety 
of radionuclides [90-98]. The projections were simulated for a low-energy, ultra-high-resolution 
collimator at 120 projection views over a 360° body-contouring orbit and a 0.2-cm projection bin 
size. Prior to simulation, the phantom was placed on a patient bed obtained from a CT scan of the 
bed on a Siemens Symbia SPECT/CT system. This bed constrained the orbit, especially for small 
phantoms.  
The renal activity and relative activity concentrations for structures inside the kidney (the 
renal cortex, medulla, and pelvis) were randomly sampled from truncated Gaussian distributions 
with the means and standard deviations derived from the PK model and 47 sets of patient data 
acquired at the Boston Children’s hospital. These parameters are summarized in Table 3.1. Each 
individual organ projection was scaled by its relative uptake value and the product of AA, 
acquisition duration, and scanner sensitivity. 
A projection of the entire phantom was generated by summing these individual sets of 
scaled organ projections. Simulated projections were scaled to represent AA-levels (AA relative 
to the standard weight-based AA) varying from 25% to 150% in increments of 25%. Poisson noise 
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was then simulated using a Poisson distributed random number generator. A total of 207,360 sets 
of projection images were thus generated: 64 uptake realizations × 6 count levels × 5 ages × 3 
height percentiles × 2 genders × 3 kidney sizes × 3 defect locations × 2 defect statuses (present or 
absent). 
 
4.2.5 Image reconstruction and post-reconstruction processing 
 
Images were reconstructed using filtered backprojection (FBP) and post-filtered with 3D 
Butterworth filters with an order of 8. We determined the optimal cutoff frequency for a 3D post-
reconstruction Butterworth filter based on the AA giving the highest AUC at each count level. The 
optimal cutoff frequency was 0.6 cycles per cm for all the count levels investigated. This cutoff 
frequency was used for all the AUC values presented below. The reconstructed images had cubic 
voxels with a side of length of 0.2 cm. Images centered on the defect with a size of 128x128 pixels 
were extracted from the coronal, transaxial, and sagittal slices containing the defect centroid and 





Figure 4.2.  From top to bottom the images show upper, lateral, and lower pole (from left to right) defects for 
the 50th height percentile for the 1- and 5-year-old female and 10- and 15-year-old male phantoms.  
 
4.2.6 Model observer 
 
The channelized Hotelling observer (CHO), first proposed by Myers and Barrett [45] has 
been shown to provide good predictions of human performance on detection tasks for a variety of 
nuclear medicine imaging applications[38, 44, 46, 47]. The CHO uses a set of frequency channels 
applied to input images that model the human visual system combined with the Hotelling Observer, 
which approximates the Ideal Observer in cases where the input data are multi-variate normally 
(MVN) distributed with equal covariance matrices. 
As noted, the Hotelling Observer is strictly optimal only when the input data (i.e., the 
vectors of channel outputs) are MVN distributed; conversely, it performs poorly when the input 
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data are multimodally distributed [86, 99]. The data used in this study, as discussed below, 
included both background and signal variations and were non-MVN. Thus, instead of the 
traditional CHO, we used a multi-template strategy proposed by Li et al. to handle the non-MVN 
data. This strategy involves partitioning the data into sub-ensembles that are approximately MVN 
and applying the optimal linear discriminant to each sub-ensemble[86]. We used a leave-one-out 
training-testing strategy. In this strategy, one feature vector was left-out (i.e., not used in the 
training), and the remaining vectors were used to train the observer. The observer was then applied 
to the left-out vector to produce a test statistic. This process was repeated with each vector in the 
ensemble being left-out once. This process was applied to each sub-ensemble and produced a 
number of test statistics equal to the size of the sub-ensemble. The resulting test statistics produced 
by this strategy were pooled and analyzed, using ROC analysis to estimate the AUC, which served 
as a FOM for task performance.  
 
Figure 4.3.  Images of the seven anthropomorphic DOM channels used in this work. The top and bottom rows 
show respectively the frequency channels and the spatial domain templates. From left to right the start frequencies 
and widths of the channels were 0.5, 1, 2, 4, 8, 16, and 32 cycles/pixel. The spatial templates are analytic inverse 
Fourier Transform of the frequency channels sampled at the image pixel size.  
 





In the multi-template channelized linear discriminant observer (MTCLDO) strategy, 
channel output vectors were sorted into sub-ensembles from one defect location, age, and height 
percentile. We verified visually that the resulting distributions of the channel output vectors in 
each sub-ensemble were not multi-modal and were nearly MVN distributed, as illustrated in 
Fig.4.4 below.  
 
4.2.8 ROC and statistical analysis 
 
We applied the MTCLDO to feature vectors in the sub-ensembles described above. 
Because younger ages have minimal anatomical differences between genders, we combined the 
sub-ensembles for the two genders. Thus, for newborn and 1-, 3-, and 5-year old phantoms, each 
sub-ensemble was comprised of 768 channel output vectors (64 realizations × 2 genders × 3 kidney 
sizes × 2 defect statuses). The sub-ensembles for the 10- and 15-year old phantoms were half as 
large as separate sub-ensembles used for each gender. The test statistics for all the sub-ensembles 
for all the height percentiles, genders and defect locations for a given age were pooled, ROC 
analysis was performed using the LABROC4 code [100], and the AUC calculated. This produced 
a total 5 AUC values, one for each age and for each of the 6 count levels. Bootstrapping and 








Figure 4.4.  Sub-ensemble histograms of the test statistic distributions for the no-defect (green) and with-defect 
(blue) cases for each of the seven channels. These data are for an upper pole defect in the 50th height percentile 1-
year-old phantom (including both male and female). This illustrates the near-MVN distribution of the feature 
vectors.  
 
4.2.9 Relationship of AUC to AA 
 
The goal of the following is to derive an approximate empirical relationship between the 
AUC and AA that can be used to fit the data from the model observer studies. When the test 
statistics are normally distributed under both hypotheses, the AUC under the ROC for the CHOs 




Rearranging the formula to express SNR as a function of AUC, we have 
 
In a binary classification task where the two classes have the same covariance matrices, the 
SNR of the Hotelling Observer test statistics can be expressed as 
 
where Δ?̅? is the difference in the ensemble mean difference of the two classes. Then, we can re-
write the above formula using formalism introduced by Barrett [28] to replace the total covariance 
as a sum of the object covariance matrix and quantum noise covariance matrix:  
 
where 〈Ka〉f represents the object variability, which includes the effects of anatomical, uptake and 
count level variability from patient to patient. Here, count level is proportional to the product of 
AA and acquisition duration for a given patient and imaging system. In (4), 〈Kn|f〉f denotes the 
contribution of quantum noise to the ensemble covariance matrix of the reconstructed images. The 
subscript 𝑓 denotes averaging over all objects in the sub-ensemble.   














 𝑆𝑁𝑅 = 2𝑒𝑟𝑓−1(2𝐴𝑈𝐶 − 1). (4.2) 
 
 
 𝑆𝑁𝑅2 = Δ?̅?𝐾?̂?
−1(Δ?̅?)𝑇 , (4.3) 
 
 





the SNR can be estimated as follows: [47] 
 
We now replace n with the AA and assume that the vector Δ?̅? can be replaced with a scalar 
𝐾1, representing the mean signal difference, Δ?̅?, and the proportionality constant relating n and 
AA. Similarly, we assume that the two covariance matrices can be replaced by the scalars 𝐾2, 
representing the object variability noise, 〈𝐾𝑎〉𝑓 and 𝐾3, representing the quantum noise, 〈𝐾𝐸|𝑓〉𝑓. 
This gives  
Rearranging the formula to express SNR in terms of a function of AUC yields 
 
Combining 6 and 7 gives a relation between the detectability index (𝑆𝑁𝑅2) and AA: 
 
Equations 8 and 1 can be combined to give AUC as a function of AA: 
 





















𝐴𝐴 × 𝐾2 +𝐾3
. (4.8)  
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Inverting the above formula to express AA in terms of AUC yields: 
 
Note that the relative size of the constants 𝐾2 and 𝐾3  indicates the degree that the SNR is 
limited by quantum noise rather than anatomical variability. It should also be noted that (4.10) is 
not a rigorous relationship in the sense that it ignores the vector and matrix matures of the defect 
and covariance matrices. However, as will be shown below, it is suitable for fitting AUC values 




The results from the IQ studies are summarized in Fig. 4.5, which shows the AUC for each 
phantom plotted as a function of the percentage of the AA obtained from the consensus guidelines 
[13]. Note that the guidelines do not result in the same IQ (as measured by the AUC) for the 100% 
count level. In this sense, they are sub-optimal.  The ultimate goal of this work was to provide a 
user with the AA needed to give the desired objectively-measured task-based image quality, as 
specified by the AUC, before imaging. The data in Fig. 4.5 provides a way to do this. The analytic 
expression relating AUC to AA derived above and given by Equation (4.10) was fit to the data in 
Fig. 4.5. The results of this fit are shown in Fig. 4.6 for all the patient ages. Note that the fits are 






















(2𝑒𝑟𝑓−1(2𝐴𝑈𝐶 − 1))2 × 𝐾3








Figure 4.5.  The area under the ROC curve (AUC) vs. percent AA plot for all the patient ages. The error bars are 
the 95% confidence intervals estimated using bootstrapping. 
 
 
Figure 4.6.  AUC vs. AA curves and their fitted functions. The AUC was fitted to the theoretical relationship, as 
specified in equation 4.9, relating AUC to the mean signal difference (K1), object variability noise (K2) and quantum 
noise (K3), and AA. 
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There was a monotonic and modestly saturating increase in AUC with AA, indicating that 
defect detectability was limited by quantum noise and the effects of object variability were modest 
over the range of count levels studied. The AA for a given value of the AUC increased with age. 
The curves in Figure 4.5 indicate that, for the current guidelines, the newborn and 10-year and 15-
year phantoms had similar image quality for the same fraction of the AA suggested by the North 
American expert consensus guidelines, but the 5-year and 1-year phantoms had lower image 
quality. The fitted functions provide an analytical relationship between AUC and AA, and could 
potentially be used to determine the AA required to give a desired AUC for a given patient weight. 
In previous work [8], we have shown that there were variations in image quality among 
phantoms with different weights but the same height. In [9], we showed data that suggested that 
height was not sufficient to explain variations in image quality for phantoms with the same weight 
over a range of anatomical variations. However, girth (circumference) at the level of the kidneys 
provides a more consistent correlation. To demonstrate the correlation between girth and the AUC 
values, we measured the patient girth of each of the phantoms and averaged them over height 
percentiles within one age. In clinical practice, patient girth could be estimated prior to imaging 
using a tape measure or from a previous CT image, if available. Fig. 4.7 shows a comparison of 
AA vs. girth and AA vs. weight at a fixed AUC for all the patient ages. The colored lines connect 
the nearest phantoms in age. These data indicate that the relationship between girth and AA is 
more robust than it is between weight and AA. The Pearson product-moment correlation 
coefficients between AA and weight and girth were 0.941 and 0.985, respectively. This again 










This study demonstrated that the current consensus guidelines, which scale activities based 
on patient weight subject to minimum and maximum activity constraints, do not give the same 
image quality for patients with different weights. Further, this study provided a relationship 
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between diagnostic image quality, as measured by AUC, and AA for 99mTc-DMSA pediatric 
SPECT for a set of phantoms having different weights. These fitted functions could potentially be 
used to determine the appropriate AA for desired level of image quality for a given patient weight. 
However, the data suggest that patient girth at the level of the kidney may ultimately be a better 


















Chapter 5 multi-slice, multi-view anthropomorphic model observer for 
visual detection tasks performed on volume images 
DeepAMO: a multi-slice, multi-view anthropomorphic 





Often, the quality of a medical image is measured in terms of the physical properties of the 
image, such as image contrast, spatial resolution, and noise level [33]. Fidelity-based measures, 
such as root mean squared error (RMSE), peak signal-to-noise ratio (PSNR), and structural 
similarity index (SSIM), have also been widely used in the medical imaging community. These 
measures are appealing because they are relatively easy to compute, have straightforward physical 
interpretations, and can provide objective quantitative measures of image quality. However, they 
are not directly related to the diagnostic task that is performed with the images, and thus may not 
be clinically relevant. Clinically relevant image quality assessment should be with respect to the 
task that is to be performed [26-32]. Ideally, the observers would be drawn from the population of 
people performing the task, i.e., for medical images, a radiologist or nuclear medicine physician. 
However, in practice, especially in large-scale developmental research studies, the use of human 
observers (and especially physicians) is too time-consuming, inconvenient, and expensive. Thus, 
a great deal of work has gone into the development of anthropomorphic model observers that 
predict human observer performance [34-37]. 
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Task-based measures of image quality based on model observers has been advocated by 
several investigators over the years, starting from Harris [101], and including Hanson and Myers 
[102], Wager et al. [103], Judy et al. [104], and Myers et al. [34, 105]. However, existing model 
observers are often not directly applicable to diagnostic tasks [106]. For example, as described 
below, commonly-used model observers are strictly valid only for signal-location-known (exactly 
and statistically) tasks. In addition, while these observers predict rankings of human observer 
performance, they often require the use of concepts such as internal noise to match the absolute 
performance of human observers. 
Of the existing anthropomorphic observer models, the channelized Hotelling observer 
(CHO) has been the most widely used as a substitute for human observers in signal-location-known 
tasks in nuclear medicine imaging research [40]. Please refer to section 2.4.3.3 for a detailed 
introduction to the CHO as well as discussions of its limitations.  
Another gap between current anthropomorphic observers and the real clinical task is that 
current model observers have been primarily designed for analyzing 2D images. By contrast, many 
clinical tasks require the interpretation of 3D datasets. This often involves reviewing sequences of 
2D slices in 3 orthogonal orientations (coronal, sagittal, and transaxial). Existing multi-slice [107, 
108] or 3D model observers [109-113] are either for SKE tasks only or single-orientation SKS 
tasks [107]. 
In this paper, we propose a novel deep learning-based anthropomorphic model observer 
(DeepAMO) that evaluates multi-orientation, multi-slice image sets to model the clinical 
diagnostic process of a radiologist or nuclear medicine physician in a clinically realistic 3D defect 
detection task. The DeepAMO was evaluated on an SKS/BKS tasks using a realistic anatomical 
background with variation in organ uptake and defect position (and thus orientation and shape). 
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We also propose a novel calibration method that ‘learns’ the underlying distribution of the human 
observer rating values (including the internal noise) using a Mixture Density Network. Note that 
in this context a rating value is the raw data from human observer study and is a numeric value 
expressing the observer’s level of confidence that a defect is present or absent in a given image. 
The entire network is trained using human observer rating values so that the output, when applied 
to an input image volume, is a rating value designed to reproduce the performance of human 
observers.  
A human observer study was conducted using the volumetric display format routinely used 
at Boston Children’s Hospital (BCH) for clinical interpretation. Quantitative comparisons of the 
performance between the DeepAMO and human observer are provided in the results section.  
 
5.2 Materials and methods 
 
Image quality in this work was measured in terms of performance on the task of detecting 
renal functional defects in 99mTc-DMSA SPECT. The images used were simulated based on an 
anthropomorphic digital phantom of 5-year-old (a typical age in DMSA imaging). The phantom 
and simulation methods are described in [1]. The simulation modeled administered activities (and 
thus noise levels) based on the North America Consensus Guidelines[114]. Task performance was 
evaluated using both human observers and the proposed DeepAMO. Both of these observers 
produced a set of rating values for images where the true defect status was known. These rating 
values were analyzed using receiver operating characteristic (ROC) analysis methods [115]. The 




5.2.1 Materials and methods 
 
The projection data for this study were generated using the Advanced Laboratory for 
Radiation Dosimetry Studies (ALRADS) UF NHANES-based phantom [116]. The pediatric 
phantom used was developed at the University of Florida based on demographic data from the 
CDC’s National Health and Nutrition Examination Survey (NHANES) data [79]. For this study, 
we used a 5-year-old male phantom with average girth and kidney size. The phantom was digitized 
using 0.1 cm cubic voxels. Activity uptake in the kidneys was modeled using data from a single 
imaging time point (3 hours post-injection). A dataset of 47 patients acquired at the BCH was used 
to estimate the means and standard deviations of kidney uptake in units of activity.  
The model previously described in [2, 117] was used to simulate defects in the cortical wall 
of the right kidney consisting of volumes of reduced uptake consistent with focal, acute 
pyelonephritis. The defects were created at random locations (excluding the area close to the renal 
pelvis) along the cortical wall. Based on input from an experienced pediatric nuclear medicine 
specialist, we selected a defect volume of 0.5 cm3 as a defect size that is clinically relevant for the 
5-year-old. 
Using this model, we created four randomly located focal transmural renal defects at each 
of the following macro locations on the right kidney cortex: upper pole, lower pole, and lateral. 
There was a total of 12 random locations for the defects generated in this study, modeling an SKS 
task. We simulated noise-free projection data for the renal cortex, medulla, pelvis, liver, spleen, 
and background (including all other organs), modeling the physics and acquisition parameters 
appropriate for 99mTc renal SPECT. The renal activity and relative activity concentrations for 
structures inside the kidney (the renal cortex, medulla, and pelvis) were randomly sampled from 
truncated Gaussian distributions with the means, standard deviations, minima, and maxima derived 
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from 47 sets of patient data acquired at BCH. Parameters for the distributions can be found in [2]. 
Each single-organ projection was scaled by the product of administered activity (AA), acquisition 
duration, and scanner sensitivity. The projections were generated using an analytic projection code 
that modeled attenuation, the spatially varying collimator-to-detector response [81], and object-
dependent scatter [82]. The code has been previously validated by comparison to Monte Carlo and 
experimental projection data for imaging of a variety of radionuclides [90-98]. 
In this study, the projections were simulated to model a Siemens low-energy, ultra-high-
resolution (LEUHR) collimator used routinely at BCH for pediatric DMSA studies.  Each single-
organ projection dataset was generated at 120 projection views over a 360° body-contouring orbit 
with a 0.1-cm projection bin size and then collapsed to a bin size of 0.2 cm. A model of the patient 
bed obtained from a CT scan of the bed of a Siemens Symbia SPECT/CT system was added to the 
attenuation map of each computational phantom.  Noise-free projection images of the entire 
phantom were obtained by summing the individual sets of scaled organ projections. Noisy 
projections were created by simulating Poisson noise using a Poisson pseudo-random generator. 
  A total of 384 projection images were thus generated, comprised of 16 uptake realizations 
× 12 defect locations × 2 defect statuses (present or absent). The mean (noise-free) activity 
distribution was statistically independent for each of these 384 projection images since the kidney 
uptake and the activity concentration ratio of the cortex to the medulla plus pelvis activity were 
randomly sampled. 
  We followed the clinical reconstruction protocol routinely used at BCH. Projection images 
were reconstructed using the OS-EM iterative reconstruction algorithm with compensation for the 
geometric collimator-detector response and post-filtered with a Gaussian filter with an FWHM of 
5 mm. The reconstructed images were then interpolated and formatted to match the volumetric 
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image display used at the BCH. In this display, 10 coronal, 20 sagittal, and 18 transaxial images 
with sizes of 96  96 pixels were generated. These composite images were used for training and 
testing of the proposed model observer and the human observers. Windowing was used to map the 
image pixel values to a range of 0 to 255. A sample of BCH’s volumetric image display is shown 
in Fig.  5.1. 
 
 
Figure 5.1.  A sample 48-slice image shown in the volumetric display format routinely used in clinical practice at 
the Boston Children’s Hospital. 
5.2.2 Proposed model observer: overview 
 
The DeepAMO is designed based on a hypothetical model of the image interpretation 
process of a human observer. One alternative of this approach would be to let the neural network 
‘learn’ how humans interpret 3D image volumes from the data. For example, the most direct 
approach would be to input the 3D image volume data into a fully connected network, and then to 
train that network directly with human observer rating values. Such a network would have a large 
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number of parameters. Since each trial (reading of a set of images by a human observer) provides 
a single scalar rating value, it provides relatively little information for training the network. A very 
large number of input rating values would thus be required. Since the rating value data is very 
expensive to obtain, we have divided the network into stages that are designed to require less 
human-observer training data. The division of the model is based on how humans interpret the 
images, as will be described below. The first two stages do not require human observer training 
data, and the third one maps a low-dimensional feature vector to a scalar rating value.  
We hypothesize that a human observer interpreting an image first scans over the orthogonal 
slices to identify suspicious abnormalities in single slices. If a defect is suspected to be present in 
one slice (of a particular orientation), the observer confirms that on adjacent slices. The observer 
would confirm that a defect in one orientation is seen in the other two orthogonal orientations. We 
suppose that the observer would have more confidence in the presence of a defect if it is found in 
at least one other orientation.  
Thus, we propose to implement this decision-making process in 3 sequential stages. In 
stage 1, we use a segmentation network to identify defects in three orthogonal slice views. The 
segmentation is performed using groups of 3 adjacent slices. In stage 2, we use deterministic 
algorithm that confirms the presence of defects in the 3 orthogonal views and generates a low-
dimensional feature vector. In stage 3, we use a Mixture Density Network to learn the mapping of 






Figure 5.2.  A schematic of the proposed model observer: DeepAMO. 𝐼 is the multi-slice, multi-view input image, 
𝑇𝑘
𝑗 is the triad where 𝑘 ∈ (𝑐, 𝑠, 𝑡) represents the slicing direction and 𝑗 ∈ [1, 𝑁 − 1], where N is the number of slices 
in each orientation. 𝑆𝑀𝑘
𝑗 is the output segmentation mask for each triad 𝑇𝑘
𝑗
. 𝑇𝑉𝐷𝑘 is the total volume of the defect 
seen in each slicing direction computed by summing the corresponding 𝑆𝑆𝑀𝑘 .  𝑆𝑆𝑀𝑘is the summed segmentation 
mask along each slicing direction 𝑘. 𝐻𝑃𝑘 and 𝑉𝑃𝑘 are horizontal and vertical projection of the corresponding 𝑆𝑆𝑀𝑘. 
𝐷𝐶𝑐𝑠, 𝐷𝐶𝑐𝑡, and 𝐷𝐶𝑠𝑡 are the three defect confirmation scalars from the defect confirmation network. 
 
5.2.3 Proposed model observer: architecture 
 
A schematic of the proposed DeepAMO is shown in Fig. 5.2. The input to the segmentation 
network was the same set of slices used in the previously described volume display used in clinical 
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practice, which consists of multiple slices in each of the three orientations: coronal, sagittal, and 
transaxial. Mathematically, the slice, 𝑆𝑘𝑖 (𝑚, 𝑛), and input composite image, 𝐼(𝑚, 𝑛, 𝑞), are related 
as follows 
In (1), 𝑞𝑘𝑖  is the index number for the 𝑖th slice in the slicing direction 𝑘 ∈ (𝑐, 𝑠, 𝑡), and 𝑚, 𝑛, and 
𝑞 are pixel indices for the x-, y-, and z-axis, respectively.  
 For each orientation, 𝑁 − 2 (N + 1 slices in each orientation) triads are generated: the first 
and last slices cannot act as the central slice for a triad. The 𝑗th triad in the slicing direction 𝑘 is: 
The output segmentation mask (SM) of each triad is a 2D binary mask of pixels thought to 
be in the defect. The SMs along each orientation are summed to form a summed segmentation 
mask (SSM) in order to enhance the defect signal(s) that is (are) present in that orientation. That 
is: 
 𝑆𝑀𝑘
𝑗(𝑚, 𝑛) = 𝑓 (𝑇𝑘
𝑗(𝑚, 𝑛, 𝑞)),  and (5.3) 
 𝑆𝑆𝑀𝑘(𝑚, 𝑛) = ∑ 𝑆𝑀𝑘
𝑗(𝑚, 𝑛),
𝑛𝑘
𝑗=1  (5.4) 
with 𝑗  the triad number and 𝑘  the slicing direction. 𝑇𝑘
𝑗
(𝑚, 𝑛, 𝑞)and 𝑛𝑘  represent the 𝑗 th triad 
and the number of triads in slicing direction 𝑘, respectively. Here, 𝑓(∙) denotes the segmentation 
network. 
We propose to implement the process of confirming defect presence in other slicing 
directions, by projecting and comparing defect information from different slicing directions, 
through a defect confirmation network. Specifically, this is implemented by projecting (i.e., 
   𝐼(𝑚, 𝑛, 𝑞𝑘𝑖 ) = 𝑆𝑘𝑖 (𝑚, 𝑛). (5.1)  
 𝑇𝑘
𝑗(𝑚, 𝑛, 𝑞) = {𝑆𝑘
𝑖−1(𝑚, 𝑛), 𝑆𝑘
𝑖 (𝑚, 𝑛), 𝑆𝑘
𝑖+1(𝑚, 𝑛)}  




summing) each 𝑆𝑆𝑀𝑘  vertically and horizontally and calculating the dot products between the 
resulting horizontal projections (HP) and vertical projections (VP) from different slicing directions. 
The HPs and VPs are derived as follows: 
 𝐻𝑃𝑘(𝑛) = ∑ 𝑆𝑆𝑀𝑘(𝑚, 𝑛)𝑀−1𝑚=0 , and (5.5) 
 𝑉𝑃𝑘(𝑚) = ∑ 𝑆𝑆𝑀𝑘(𝑚, 𝑛),𝑁−1𝑛=0  (5.6) 
with M and N being the number of pixels in the x- and y-axis directions, respectively.  
The projection is constructed so that the projections from the different slicing directions 
are along the same direction in space. To understand this, consider that any two views always share 
a common axis, and, by projecting the two views onto this common axis, we can confirm 
information about defect location that is compatible. For example, consider an L-shape object in a 
3D space (Fig. 5.3). By projecting the sagittal and transaxial views vertically, we get two 1D 
vectors that both contain information about the object’s maximum length along the horizontal axis. 
If the dot product between the two 1D vectors is large, then the object is present at the same 
location in that direction for both slicing directions. Likewise, we can confirm the object’s location 
along the other two directions via the same projection and dot product operations. This process 
yields 3 scalar values, representing the defect agreement along the x, y, z-axis, respectively. We 
named these 3 scalar values the defect confirmation (DC) scalars. They are derived from the HPs 
and VPs from different slicing directions as follows 
 𝐷𝐶𝑐𝑠 = 𝐻𝑃𝑐(𝑛) ∙ 𝑉𝑃𝑠(𝑚), (5.7) 
 𝐷𝐶𝑐𝑡 = 𝐻𝑃𝑡(𝑛) ∙ 𝑉𝑃𝑐(𝑚), and (5.8) 
 𝐷𝐶𝑠𝑡 = 𝑉𝑃𝑡(𝑚) ∙ 𝑉𝑃𝑠(𝑚). (5.9) 
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The DC scalars are concatenated with the total volume of the defect (TVD) seen in each 
slicing direction to form a single feature vector. The TVD from each slicing direction is computed 
as follows: 
 
The resulting 6-element concatenated feature vector is then sent to a Mixture Density 
Network (MDN) [118] to generate the rating (test statistic) value. The dense layers in the MDN 
are meant to model the process of a human making the final decision using combined information 
from the different directions. The output of the MDN is the set of parameters of a statistical 
distribution, in this case a Gaussian Mixture Model, as described below. 
 
 
Figure 5.3.  An illustration of the process of confirming the defect from different views using projection and 
dot product in 3D space. 
 
 









5.2.4 Calibration to human observer data via a mixture density 
network 
 
For defect detection tasks, the observer performance is usually measured by the AUC, 
which ultimately depends on the underlying distribution of the rating values given by the observer. 
Thus, for the purposes of replicating an observer’s AUC, we propose to directly learn the mapping 
of feature vectors to the distribution of the rating values. We hypothesize that more training and 
testing samples would help better capture the underlying rating value’s distribution. However, 
demonstrating the equivalence of the distributions is a task requiring a large number of rating 
values. In addition, it is unclear what level of agreement between the true and modeled distribution 
is required. Thus, we are focusing in this work on verifying that the model observer can replicate 
the AUC values obtained from the set of rating values resulting from an observer study.  
A mixture density network (MDN) was chosen for the task of mapping the input feature 
vector into a rating value in order to model the fact that a human observer will give a different 
rating value for the same input image. The MDN provides parameters of a distribution that can 
then be sampled to provide multiple, continuously valued ratings from a single set of input feature 
vectors. This can be useful during testing of the DeepAMO to reduce sampling error. 
Typically, an MDN learns an entire probability distribution for the output by modeling the 
conditional probability distribution of the target data conditioned on the input data. In our case, 
the desired conditional probability distribution is  𝑃(𝑟|𝑿), where is 𝑿 = [𝑥1…𝑥6] a 6-element 
feature vector and 𝑟 is a (continuous) human observer rating value for a given input feature vector. 
For the purpose of modeling any arbitrary probability distribution, the MDN uses a Gaussian 
mixture model as the conditional probability density function, which can be represented as a linear 
combination of kernel functions in the form  
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where 𝑚 is the number of components in the mixture and {𝜋𝑖(𝑿)} is the set of mixture coefficients 
for the kernel functions, which sum to 1. The set {𝜋𝑖(𝑿)} is derived from the output of the MDN 
and is converted to a set of probabilities as follows:  
 
with 𝜋𝑖  the output from the last dense layer, as shown in Fig. 5.3. The kernel functions, {𝜙𝑖(𝑟|𝑿)}, 
are in the form of Gaussian distributions 
 
where 𝜎𝑖(𝑿) and 𝜇𝑖(𝑿) are the estimated standard deviation and mean for the input feature vector, 
𝑿, and they come from the output of the last dense layer. Note that {𝜋𝑖(𝑿)}is a function of 𝑿. So, 
{𝜋𝑖(𝑿)} can also be regarded as a set of prior probabilities of the target data. 
In training, the loss is computed using the human observer rating value,  𝑟𝑡𝑟𝑢𝑒 , and the 
predicted mixture distribution 𝑃(𝑟|𝑿) from the MDN as follows 
 
In testing, a rating value is predicted by first randomly sampling the mixing coefficients 
and then sampling from the Gaussian distribution corresponding to that sampled mixing coefficient 
with its corresponding mean and standard deviation. Multiple sample rating values can be 



























Figure 5.4.  Segmentation network architecture used in this study 
 
5.2.5 DeepAMO performance on unseen images 
 
To estimate the number of images needed to train the DeepAMO, we used simulated 
feature vectors and rating values to train and test the MDN. The criterion for judging the number 
of images to be sufficient is the statistical confidence level needed in comparing AUC values 
between the proposed model and human observer. We assumed the elements of the feature vectors 
and the rating values follow a (unimodal or multi-modal) Gaussian distribution. 
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The feature vectors were simulated by first generating values for the 𝑇𝑉𝐷𝑘, one for each 
orientation. Each 𝑇𝑉𝐷𝑘was assumed to be mutually independent and was generated by sampling 
from independent Gaussian distributions. The sampled 𝑇𝑉𝐷𝑘 values were then used to calculate 
the means and standard deviations of the DC scalars, which were also assumed to follow a 
Gaussian distribution. 
 𝜇𝑐𝑠 = 𝑇𝑉𝐷𝑐 × 𝑇𝑉𝐷𝑠, (5.15) 




 𝜇𝑐𝑡 = 𝑇𝑉𝐷𝑐 × 𝑇𝑉𝐷𝑡, (5.17) 




 𝜇𝑠𝑡 =  𝑇𝑉𝐷𝑠 × 𝑇𝑉𝐷𝑡 , and (5.19) 
 𝜎𝑠𝑡 =  
𝜇𝑠𝑡
3
.     (5.20) 
The rating values of each feature vector were sampled from multi- or uni-modal Gaussian 
distributions. The distribution parameters for these simulated rating values were derived 
qualitatively from distributions of rating values from human observer studies and are shown in 
Table 5.1. For each feature vector, we then sampled N rating values from the assumed distribution 
to simulate the appropriate level of inter- or intra-observer variability in the data. Specifically, in 
this work, we sampled 2 rating values for each feature vector. So, there were 15,000 (2,500 × 3 
feature vector types × 2 repeated samples) feature vector and rating value pairs in total for the case 
that had 2,500 samples/feature vector type, and 30,000 in total for both the defect-present and 
defect-absent cases. 
In the simulation experiment, we generated 3 types of feature vectors for each class (defect-
present and defect-absent): definitely-present, equivocal, and definitely-absent, reflecting different 
levels of user confidence in making the decision. For example, the feature vectors that belong to 
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the definitely-present type in the defect-present class were generated by sampling 3 large values 
for the 3 𝑇𝑉𝐷𝑘s, modeling a high level of success of the segmentation network in detecting the 
defect in slices from all 3 orientations.  The other two types (equivocal and definitely-absent, 
respectively) contained 2 and 1 large values (assigned randomly to any of the three orientations) 
in the 𝑇𝑉𝐷𝑘 s to simulate different degrees of success in detecting the defect in the three 
orientations.  




Definitely-yes Not-sure Definitely-no 
Rating value means 7 10 2 4 -3 
Standard deviation 1.2 0.2 1.2 1.2 0.2 
Component weight 0.5 0.5 0.5 0.5 1 
       
Defect-absent feature 
vector type 
Definitely-yes Not-sure Definitely-no 
Rating value means -10 -8 -2 -4 2 5 
Standard deviation 0.2 1.2 0.7 1.2 0.5 0.8 
Component weight 0.5 0.5 0.5 0.5 0.5 0.5 
 
5.2.6 Training and testing of DeepAMO 
 
The proposed model observer was trained in two stages. First, the segmentation network 
was trained given the ground-truth defect segmentation masks. Next, the MDN was trained using 
the output from the trained segmentation network and the human observer rating values.  
The segmentation network was trained with triad images and their corresponding binary 
defect segmentation labels. Since each defect only contained about 0.5% of the kidney cortex 
volume, the number of defect-present triads was much smaller than the defect-absent ones, making 
this a highly imbalanced dataset. Thus, we adopted data augmentation of the defect-present triads 
to balance the training data. We enriched the data by forming an additional seven sets of raw 
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images and their labels by rotating each original defect-present triad image by 90, 180, and 270 
degrees and flipping them and the original dataset upside down. The exponential logarithmic loss 
in [119] was adopted to emphasize segmentation of small structures with the best-performing 
weights (𝜔𝑐𝑟𝑜𝑠𝑠 = 0.2 and 𝜔𝐷𝑖𝑐𝑒 = 0.8).  
For the segmentation network, we adopted a shallow version of the U-Net [120]. We used 
a shallow (in depth) network due to the relatively small amount of training data available in this 
study; a deeper network might be needed for a larger number of signal and anatomical variations. 
The architecture of the segmentation network used in this study is shown in Fig. 5.4.   Gaussian 
noise with a standard deviation of 1.0 was added to the renormalized input image (ranges 0-255) 
to prevent overfitting. We searched for the optimal network capacity (depth) for the segmentation 
network. There was a tradeoff between producing the highest Dice score and using the smallest 
number of parameters. However, it was observed that there was a relatively small increase in Dice 
score with increased number of parameters in the tested network architectures, and the Dice scores 
were all reasonably high. So, we adopted the network architecture that had the smallest number of 
parameters and yet gave a reasonably high Dice score (0.97). The train and test datasets had 12,288 
and 3,072 triads, respectively. Data augmentation was done on-the-fly. We used an Adam [121] 
optimizer with a learning rate of 0.001 and a batch size of 200.  The training took about 2 hours 
(~100 epochs) to converge on a single Tesla K40 GPU.  
For the MDN, the number of mixtures was chosen by visually inspecting the distribution 
of the target human observer’s rating values. The number of mixtures was selected to be equal or 
greater than the number of modes observed in the distribution of the observer’s rating values. For 
this study, we used a MDN with three fully connected dense blocks each with 128 dense units and 
a dropout rate of 0.5. Each dense block contained a dense layer with the above mentioned dense 
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units and a batch normalization layer, followed by a ReLU activation and dropout layer. The 
outputs from the last dense block were then connected to three dense layers which, repsectively, 
output the mixing coefficients 𝜋𝑖(𝑿) , means 𝜇𝑖(𝑿) , and sigmas 𝜎𝑖(𝑿)  for the estimated 
distribution. The number of mixing coefficient was set to 5 since we obseverd about 5 modes in 
the distribution of huamn observers’ rating vlaues.  
 
Figure 5.5.  A sample image of the GUI used in the human observer study for DeepAMO 
 
5.2.7 Human observer study 
 
  The same image display format shown in Fig. 5.1 was used in the human and model 
observer studies. A sample display of the human observer GUI is shown in Fig. 5.5. In the study, 
the observer was asked to rate their confidence that a defect was present on a continuous scale 
ranging between 1 to 5 (later mapped to -10 to 10), with the highest number representing the 
greatest confidence that a defect was present. To familiarize themselves with the display program 
and the nature of the clinical defect detection task, all observers participated in an initial training 
session comprised of 24 images. In the training session, phantom images of the kidney cortex were 
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provided as ground truth to the observers once their rating value was recorded. Additional training 
was done as described below. Rating values from the training study were not used in training the 
network. 
 Two senior medical imaging physics Ph.D. students participated in the human observer 
study. A total of 384 of the composite images described in section 5.2.1 were used. To simulate an 
SKS detection task, the train and test datasets were created without requiring a balance of defect 
locations. Thus, the test dataset could contain defect locations that were not present in the initial 
training dataset. The images were divided into an initial training set and three test blocks. The 
block layout for each observer is shown in Table 5.5. In each test block, a refresher set of 24 images 
was provided to refresh the observer’s memory about the task. A total of 288 rating values was 
collected from each observer. 











  24 1 24 training 24 

















Figure 5.6.  A pictorial illustration of the rejectable and unrejectable case in equivalence hypothesis testing. 
 
5.2.8 Equivalence hypothesis testing 
 
An equivalence statistical hypothesis test [122] was conducted to test whether the 
performance (as measured by the AUC) of the human observer and the proposed model observer 
was statistically equivalent on a defect detection task. The null hypothesis and alternative 
hypothesis are expressed as follows: 
 
where 𝐴𝑈𝐶𝐻𝑂 and 𝐴𝑈𝐶𝑀𝑂 , respectively, are the AUC values for the human and proposed model 
observer; 𝛿 is a threshold for an important difference (margin of difference) between 𝐴𝑈𝐶𝐻𝑂 and 
𝐴𝑈𝐶𝑀𝑂 . The difference parameter was used as it is very difficult, if not impossible, to show 
statistically that two quantities are exactly equal. In addition, small differences are not practically 
important. The difference parameter was prespecified and is a determinant of sample size: in order 
to prove better equivalence (smaller 𝛿), a larger sample size is required. In order to reject the null 
hypothesis, the confidence intervals of the difference of the AUCs must lie within the interval 
 𝐻0: |𝐴𝑈𝐶𝐻𝑂 − 𝐴𝑈𝐶𝑀𝑂| = 𝛿 and 
 





defined by the margin of difference parameter, as described in [122] and illustrated in Fig. 5.6. For 
this study, we set 𝛿 to 0.043. That is, as long as the confidence intervals of ∆AUC were found to 
be smaller than 0.043, the null hypothesis can be rejected and equivalence of the human and model 
observer can be claimed. 
In order to calculate the confidence intervals for the differences in the AUCs (∆AUCs), we 
conducted a 5  2-fold cross-validation experiment using data generated by the two human 
observers. A total of 576 rating values (288 images  2 observers) was used in training and testing 
of the proposed model observer. The data were partitioned randomly for each of the five trials, and 
a 50-50 train-to-test fraction was adopted. Within each trial, the train and test data were switched 
between the 1st and 2nd fold. We used a 50-50 split strategy to divide the data, as we assumed that 
the number of images in the test dataset should not be too small otherwise the distribution of rating 
values produced would be too coarse to represent the observer’s true performance, thus resulting 
in unfair AUC comparisons. However, we have not investigated whether the 50-50 splitting is 
optimal.  
5.2.9 Comparison of DeepAMO to a scanning-linear observer 
 
A scanning linear discriminant observer (SLDO) study was conducted using the same 
reconstructed images as described in section 5.2.1. However, since the scanning observers cannot 
operate at the location on which they were trained, we had to limit the SLDO input image to only 
slices that could actually contain a defect. Here, it is worth noting that this input format has 
significantly reduced the difficulty of the clinical defect detection task by filtering out the defect-
absent slices. This eliminates the chance of making a mistake, e.g., due to the presence of a noise 
artifact in these slices, as described in section 5.2.2.  
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In the SLDO study, we used a 3-slice composite image as the input. The composite image 
was formed by extracting the coronal, transaxial, and sagittal slices containing the defect centroid 
from the 3D reconstructed image. All slices had a size of 128 × 128 pixels and their defect centroid 
shifted to the center of the image. Samples of the defect-present and defect-absent composite image 
are shown in Fig 5.7. We used seven non-overlapping rotationally symmetric difference-of-mesa 
channels. The starting frequency and the width of the first channel was 0.5 cycles per pixel, and 
subsequent channels had widths that doubled and abutted the previous channel. The frequency 
domain channels and corresponding spatial templates are shown in Fig. 5.8.  
 
 
Figure 5.7.  Top and bottom row shows the defect-present and defect-absent composite image at two different 







Figure 5.8.  Images of the seven anthropomorphic DOM channels used in this work. The top and bottom rows 
show, respectively, the frequency channels and the spatial domain templates. From left to right, the start 
frequencies and widths of the channels were 0.5, 1, 2, 4, 8, 16, and 32 cycles/pixel. The spatial templates are the 
analytic inverse Fourier Transforms of the frequency channels sampled at the image pixel size.  
 
 
Each of the seven spatial domain templates was applied to each of the 3 images (transaxial, 
sagittal, and coronal) to give a 21-element feature vector. Each element in the resulting feature 
vector was obtained by taking the dot product of a spatial domain template with an input composite 
image. These feature vectors served as inputs to train and test the SLDO as described below. 
To apply the SLDO on a test image, we first generated N (N = number of signal variations) 
feature vectors of each test image, corresponding to features taken at the N different defect 
locations. Then, we trained a different SLDO on the feature vectors at each of the 12 potential 
defect locations. Then, for each test image, we applied each of the 12 SLDOs to the feature vectors 
from each of the potential defect locations, producing a set of 12 test statistics. We then applied 
the argmax operator to select the largest such test statistic, and this served as the test statistic for 
this test image. We used a leave-one-out training-testing strategy. In this strategy, one feature 
vector was left-out (i.e., not used in the training), and the remaining vectors were used to train the 
observer. In our case, the feature vector corresponding to the ground-truth defect location of the 
test image was left out in training the SLDO for that defect location. The trained SLDO was then 
applied to the left-out vector to produce a test statistic for that defect location. ROC analysis was 
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performed on the test statistics using the LABROC4 code [100], and the AUC calculated. 
Bootstrapping and nonparametric analysis were used to compute 95% confidence intervals for the 
AUC value. 
A separate human observer study was conducted using the same input format (3-slice 
composite image) as was used in the SLDO study. Again, two senior medical imaging physics 
Ph.D. students participated in the human observer study. A total of 384 of the composite images 
as described above were used.  The same block layout as in the human observer study for 
DeepAMO was used in the human observer study. A sample display of the human observer GUI 
is shown in Fig. 5.9. A total of 288 rating values was collected from each observer. 
 
 





5.3.1 DeepAMO on simulated data 
 
 
The results (Fig. 5.10) show the degree of similarity between the histograms (distributions) 
of the simulated test data (simulated unseen data); the degree of similarity increased as the total 
number of samples increased, indicating that the MDN was capable of handling complex 
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distributions of observer’s rating values. This result agrees with the hypothesis that the MDN 
requires a modest amount of training data in order to learn the underlying behavior of the observer 
on unseen data. Here, we assumed that the underlying behavior of the observer was encoded in the 
distribution of that observer’s rating values (training data).  
The results also demonstrated that there is a tradeoff between ∆AUC and the total number 
of samples in the dataset. Bootstrapping was used to calculate the non-parametric confidence 
intervals on the ∆AUC. The ∆AUCs and 95% confidence intervals on the ∆AUCs are summarized 
in Table 5.6. The results show that the 100, 500, and 2,500 samples/feature vector type cases had 
decreasing widths of the confidence intervals of ∆AUC, indicating that, as expected, more samples 
are needed to demonstrate greater equivalence (smaller 𝛿) between the human and proposed model 
observer. The data also suggest that training set size is an important parameter in determining the 






































Figure 5.10.  A Plots of histograms of the rating values of the simulated feature vectors (test data only) and 
predicted rating values on these data given by the DeepAMO.  The plots show the class 0 and 1(defect present 
and absent, respectively) as well as the calculated AUC value. 
5.3.2 DeepAMO test results 
 
For stage I, the highest dice score achieved on the validation data for the best segmentation 
network was 0.975. The validation was done on a balanced dataset with 50% of the triads 
containing a defect. 
The AUC values for the human observers and the corresponding DeepAMOs for the 5  
2-fold cross-validation experiment are summarized in Table 5.7. The mean and standard deviation 
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of the ∆AUC were 0.03 and 0.0204, respectively. The 95% confidence interval for the ∆AUC was 
[-0.0174, 0.0426], under the assumption that ∆AUC was normally distributed. The results of the 
study show that the null hypothesis with a margin of difference (𝛿) greater than 0.0426 can be 
rejected at a confidence level of 95%, with this training set comprised of 288 samples. The 
histograms of the rating values from the human observers and the DeepAMOs for the 5  2-fold 
cross-validation experiment are shown in Fig. 5.11. The AUC value is given at the top of each plot 
in that figure. The distributions of the rating values for the human and model observer are 
qualitatively similar. 
 
Table 5.7. Summary of stage II training results 
 
1st fold 2nd fold 



















1 0.829 0.79 0.797 0.75 0.039 0.05 0.045 
2 0.814 0.77 0.816 0.78 0.044 0.036 0.04 
3 0.814 0.82 0.815 0.77 -0.01 0.045 0.018 
4 0.82 0.77 0.809 0.8 0.046 0.007 0.027 





Figure 5.11.  Histograms of predicted rating values given by DeepAMO on unseen human observer data from 
the 3rd trial of the 5 x 2-fold cross validation experiment (other trials have similar patterns). Note that multiple 
predicted rating values were generated for each test image during testing of the DeepAMO to reduce sampling 




5.3.3 Scanning-linear Observer Test Results and its Human Observer 
Results 
The mean AUC for the scanning-linear discriminant observer and its 95% confidence 
interval were 0.992 and [1.00, 0.986], respectively. The mean AUC for the human observer study 
(3-slice composite image as input) was 0.912 with a 95% confidence interval of [0.868, 0.954], 
which is statistically significantly different from the mean AUC (0.815, 95% C.I. = [0.851, 0.780]) 
from the human observer study (48-slice composite image as input). The results indicate that the 




One limitation of this paper is that the simulated dataset has limited background 
(anatomical) and signal (shape and size) variation. However, we believe that this limitation does 
not detract from the paper’s demonstration that the proposed network architecture can model 
human observer performance. A dataset with greater anatomical and signal variations might 
require a different architecture for the segmentation network. However, as long as the 
segmentation network produced results that distinguish between the defect-present and absent 
cases at least as well as a human observer, the subsequent stages could still match that performance 
to human observer performance.   
Another limitation of this paper is the use of non-physician observers. Non-physicians were 
used because of the difficulty of recruiting physician observers to perform a study of this nature. 
While the lack of physician observers would clearly affect the clinical diagnostic task, the task that 
the observers performed in this study was limited to identifying defects in images. We believe that 
well-trained non-physicians, with sufficient training, can perform well on this more limited task. 
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In addition and more importantly, the purpose of this paper was to validate the ability of the 
proposed model observer to reproduce human observer defect detection performance, and not to 
generate data on performance that impacts a clinical task. So, even if the human observers used 
performed poorly compared to physicians, the data demonstrate that the model can reproduce their 
performance. The limitations of the human visual system that degrade performance on defect 
detection are present even for the non-physician observers, and this work demonstrates the ability 
of the proposed observer to model these limitations. Therefore, we believe that the data from the 
observers used in this study demonstrate the utility of the proposed method. 
A potential concern for the DeepAMO could be the relatively long training time (~ 2 hours) 
required by the segmentation network. On the contrary, the CHO or scanning forms of the CHO 
can provide an estimate of relative image quality, e.g., relative rankings of the methods being 
evaluated. However, the image quality results may not be valid for use in cases where the absolute 
task performance of the human observer is needed, i.e., selecting administered activity or 




We have proposed a general framework for using deep convolution neural networks as an 
anthropomorphic model observer for the task of interpreting 3D image volumes and reproducing 
human observer performance. We applied this framework in the context of a renal functional defect 
detection task in nuclear medicine imaging using realistic simulated images. The results show that 
the performances of the proposed model and human observers on unseen images were equivalent 
with respect to a margin of difference in the AUC (∆AUC) of 0.0426 at 𝑝 < 0.05, for a training 
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set of 288 samples. The proposed framework could be readily adapted to model human observer 





































Balancing dose reduction and image quality is an unmet need and important goal that has 
immediate clinical and societal benefits for pediatric patients. Lower radiation exposure to the 
patient can reduce risk and adverse effects, but can also result in reduced diagnostic image quality. 
Ultimately, it is desirable to use the lowest dose that gives sufficient image quality for accurate 
clinical diagnosis.  
This dissertation proposed and developed tools for a general framework for optimizing 
radiation dose with task-based assessment of image quality. In this dissertation, we investigated 
the tradeoff between image quality and renal defect detectability as a function of administered 
activity, acquisition duration, and measures of body habitus for pediatric patients undergoing renal 
molecular imaging procedures.  
In Chapter 3, we developed a projection image database modeling imaging of 99mTc-
DMSA, a renal function agent. The database uses a highly-realistic population of pediatric 
phantoms with anatomical and body morphometry variations in height and weight. Using the 
developed projection image database, we have explored patient factors that affect image quality. 
Image quality was measured by three surrogate indices of image quality that quantify the noise 
(renal count density), image resolution (average radius of rotation), and scatter (scatter-to-primary 
ratio). The results showed that the current weight-based guidelines, based on scaling the 
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administered activity by patient weight, are not optimal in the sense that they do not give the same 
image quality for patients with the same weight. After demonstrating that height and weight did 
not robustly predict image quality, we explored other externally-measurable factors that could 
better predict image quality.  
In Chapter 4, we have found that factors that are more local to the target organ may be 
more robust than weight for estimating the administered activity needed to provide a constant 
image quality across a population of patients. In the case of renal imaging, we discovered that girth 
at the level of the kidneys is more robust than weight in predicting administered activity needed to 
provide consistent image quality. In this work, analytical relationships between image quality and 
administered activity were derived, which could be used to determine the AA required to give a 
desired image quality for a given patient weight. However, one limitation of this work is that the 
image quality, as measured by the defect detection performance (quantified using the AUC) of an 
anthropomorphic model observer, was not verified by humans. To translate the image quality 
measures to clinical use, it is more meaningful to provide an AUC value that would be obtained 
for a human observer or ensemble of human observers. Due to the limitations (details are discussed 
in section 2.5.2) of the current model observers in modeling the clinical task involved in this work, 
the third part of this dissertation focused on developing a new model observer that can fully model 
a clinical 3D detection task. 
     In Chapter 5, we proposed a deep learning-based anthropomorphic model observer to fully 
and efficiently (in terms of both training data and computational cost) model the clinical 3D 
detection task using multi-slice, multi-orientation images sets. The proposed model observer is 
comprised of a segmentation network followed by a regression network. A human observer study 
using a total of 288 images was conducted, with medical imaging physics graduate students serving 
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as observers. A 5  2-fold cross validation experiment was conducted to test the statistical 
equivalence in defect detection performance between the proposed model observer and the human 
observer. The results show that the proposed model observer has the potential to mimic human 
observer defect detection task performance in a clinically realistic diagnostic task.  
The results and tool developed in this dissertation will help provide the data needed by 
standards bodies to develop improved dosing guidelines for pediatric molecular imaging that result 
in more consistent image quality and absorbed dose. 
 
6.1.1 A projection database of pediatric renal SPECT 
 
    The first aim of this dissertation was to build upon the Sgouros et al. work to investigate 
more completely the tradeoff between administered activity and image quality as a function of 
patient height and weight over a wide range of patient heights and weights.  
As described in Chapter 3, we generated a realistic projection database modeling pediatric 
renal 99mTc-DMSA SPECT imaging from a digital phantom population developed by our 
collaborator at the University of Florida [79]. The phantom population is comprised of 90 
phantoms with realistic variations in height, weight, and organ size. The phantoms model both 
genders at five ages (newborn, and 1-, 5-, 10-, and 15-years old). The phantoms have median (50th 
percentile) weight for their age and include variations having 10th, 50th, and 90th height 
percentiles, simulating patients having the median weight at each age with varying body habitus. 
The 10th, 50th, and 90th phantoms are referred to as short and stout, average, and tall and thin, 
respectively. In addition, three kidney masses (-15%, average, and +15%) are modeled for each 
age and height percentile.  
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We simulated variations in radiotracer uptake in 6 tissues: cortex, medulla, pelvis, spleen, 
liver, and body reminder (the remaining soft tissues of the phantom). Projections of each of these 
tissues were generated separately assuming a uniform activity distribution. The individual 
projections were then scaled by the relative organ uptakes, which were based on an uptake model 
obtained from patients. We randomly sampled scale factors to model the variation in organ uptake 
seen in patient populations. For each phantom, 384 uptake realizations, modeling random 
variations in the uptakes of organs of interest, were generated, producing 34,560 noise-free 
projection datasets (384 uptake realizations times 90 phantoms). The resulting images model the 
projection data for that patient and uptake realization per unit administered activity at a standard 
acquisition duration. We fixed the acquisition duration and investigated six count levels 
corresponding to 25%, 50%, 75%, 100%, 125%, and 150% of the original weight-based 
administered activity as computed using the North American Guidelines [78]. Scaling the 
projections by the corresponding administered activity gave the mean projections for that count 
level. Noisy projection images were created by applying a Poisson-distributed pseudorandom 
number generator.  
The results of this work showed that weight-based dosing was partially able to offset losses 
in count density due to variations in patient weight. However, it suggested that the kidney count 
density for newborns was higher than for other phantoms, suggesting that current values of 
minimum administered activity in dosing guidelines may result in over-dosing. The results also 
demonstrated variations in scatter and resolution that depend on body morphometry, and is not 
correlate completely with phantom height. The results suggested the need for more detailed task-
based studies of image quality, and that variables beyond height and weight are needed in order to 
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prescribe administered activities that equalize image quality and thus achieve as little as reasonably 
possible dosing. 
In addition to the above results, the work also provided a comprehensive method for 
efficiently simulating data from a population of realistic phantoms in the context for renal SPECT 
imaging. The set of digital phantoms, the simulation methods themselves, and the set of simulated 
DMSA projections provided tools and methods needed to expand the applications of realistic 
simulation in the optimization and evaluation of nuclear medicine and SPECT imaging.  
 
6.1.2 An investigation of the externally-measurable factors that could 
better predict image quality 
 
 
After demonstrating that height and weight did not robustly predict image quality, we 
considered other externally-measurable factors that could better predict image quality. Our general 
hypothesis is that patient body factors that closely describe morphometry in the region of the target 
organ would be most closely related to image quality. The hypothesis is based on the fact that local 
body morphometry would affect attenuation, system resolution, and scatter, and that morphometry 
away from the kidney would have little effect to image quality. For example, in the case of renal 
imaging, patients having large girth in the renal region would have more attenuating medium 
between the kidneys and the gamma camera than patients with small girth. This should result in 1) 
fewer photons escaping the body (higher noise), 2) larger camera radius of rotation (poorer 
resolution), and 3) higher scatter (poorer contrast). On the other hand, large head size would not 
affect renal image quality. Thus, in the second aim of this dissertation, we investigated whether 
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patient waist circumference (girth), kidney size and kidney depth would strongly affect image 
quality in DMSA SPECT. 
In Chapter 4, we applied task-based image quality assessment method on the simulated 
projection database as described in Chapter 3. Using this realistic phantom population and 
projection database, we conducted two experiments in order to test the hypothesis that weight and 
height are not as important factors as girth to IQ. First, we used the existing projection database 
and treated the height variations as part of the population’s anatomical variation by pooling the 
test statistics from different height percentiles together. Then, we calculated the detectability index 
(𝑆𝑁𝑅2) from the resulting AUC and fitted the following theoretical relationship relating DI to AA 
(full derivation of the theoretical relationship is not shown in the summary and is available in [2]). 
𝑆𝑁𝑅2 =
𝐴𝐴 × 𝐾1
𝐴𝐴 × 𝐾2 +𝐾3
, (6.1) 
where 𝐾1 is the mean signal difference; 𝐾2 is the object variability noise; and 𝐾3 is the quantum 
noise. Figure 6.1 shows the area under the ROC curve (AUC) vs. percent AA plot for all the patient 
ages and the Detectability Index (SNR2) vs. percent AA curves and their fitted functions, 
respectively. Note that the Detectability Indices did not cross at the 100% count level, suggesting 
that the current weight-based guidelines are not optimal. That is, they do not provide the same IQ 
for all patients. From the plot of DI vs. AA (Fig. 6.1, right), it is evident that the curves have 
different shapes. Thus, scaling of the AA by a constant factor for each age could not equalize the 




Figure 6.1.   The area under the ROC curve (AUC) vs. percent AA plot for all the patient ages and DI (SNR2) vs. AA 
curves and their fitted functions. The detectability index (DI) was fitted to the following theoretical relationship 
relating DI to the mean signal difference (K1), object variability noise (K2) and quantum noise (K3), and AA. 
 
 
Figure 6.2.  . AA vs. patient girth and weight at a fixed DI of 2.0. 
 
Fig. 6.2 shows a comparison plot of AA vs. girth and AA vs. weight at a fixed DI of 2.0 
for all the patient ages. The colored lines connect the nearest phantoms in age. These data indicate 
that the relationship between girth and AA is simpler and more robust than it is between weight 
and AA. The Pearson product-moment correlation coefficients between AA and weight and girth 
are 0.941 and 0.985, respectively. This again demonstrates that girth may be more robust for 
estimating the AA needed to provide a constant image quality. 
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This study demonstrated that the current consensus guidelines, which scale activities based 
on patient weight subject to minimum and maximum activity constraints, do not give the same 
image quality for patients with different weights. Further, this study provided a relationship 
between diagnostic image quality, as measured by AUC, and administered activity for 99mTc-
DMSA pediatric SPECT for a set of phantoms having different weights. These fitted functions 
could potentially be used to determine the appropriate administered activity for the desired level 
of image quality for a given patient weight. However, more importantly, the data suggested that 
patient girth at the level of the kidney may ultimately be a better factor to use than weight when 
selecting administered activity for this imaging task.   
 
6.1.3 DeepAMO: A multi-slice, multi-view anthropomorphic model 
observer for visual detection tasks performed on volume images 
 
Due to the limitations (details are available in section 2.5.2) of the current model observers, 
the third aim of this dissertation focused on developing a model observer that can efficiently (both 
training data and training computational cost) simulate a realistic clinical realistic 3D detection 
task using multi-slice, multi-orientation image sets.  
In Chapter 5, we developed a deep learning-based anthropomorphic model observer 
(DeepAMO) for image quality evaluation of multi-orientation, multi-slice image sets with respect 
to a clinically realistic 3D defect detection task. The input to the DeepAMO is a composite image, 
typical of that used to view 3D volumes in clinical practice. The output is a rating value designed 
to mimic human observer’s defect detection performance. The main contributions of this work are 
threefold. First, we proposed a hypothetical model of the decision process of a reader performing 
a detection task using a 3D volume. Second, we proposed a projection-based defect confirmation 
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network architecture to confirm defect present in two different slicing orientations. Third, we 
proposed a novel calibration method that ‘learns’ the underlying distribution of observer ratings 
from the human observer rating data (thus modeling inter- or intra- observer variability) using a 
Mixture Density Network. We implemented and evaluated the DeepAMO in the context of 99mTc-
DMSA SPECT imaging. A human observer study was conducted, with two medical imaging 
physics graduate students serving as observers. A 5 ×  2-fold cross-validation experiment was 
conducted to test the statistical equivalence in defect detection performance between the 
DeepAMO and the human observer. The results show that the DeepAMO’s and human observer’s 
performances on unseen images were statistically equivalent with a margin of difference (∆AUC) 
of 0.0426 at 𝑝 < 0.05,  using 288 training images. The results show that the DeepAMO has the 
potential to mimic human observer defect detection task performance in a clinically realistic 




Through the course of this work, we have made several major contributions to the 
development of an improved dosing guidelines for pediatric molecular imaging that result in more 
consistent image quality and absorbed dose. 
First, we developed a realistic projection database for investigation of relationship between 
image quality and patient morphometry in 99mTc-DMSA renal SPECT. The database generated in 
this work is immediately applicable to other pharmaceuticals labeled with 99mTc used in pediatric 
imaging such as 99mTc- MAG3 or 99mTc-MDP; only scaling and summing of the organ projections 
with appropriate scaling factors reflecting agent biokinetics. Further, the methods used in this study 
 
 126 
are applicable to studying these tradeoffs for other diagnostic and/or therapeutic 
radiopharmaceuticals in both pediatric and adult patients.  
Second, we demonstrated that the current consensus guidelines, which scale activities 
based on patient weight subject to minimum and maximum activity constraints, do not give the 
same IQ for patients with different weights. Furthermore, this study provides a relationship 
between diagnostic IQ, as measured by AUC, and AA for 99mTc- DMSA pediatric SPECT for a 
set of phantoms having different weights. These fitted functions could potentially be used to 
determine the appropriate AA for desired level of IQ for a given patient weight. However, the data 
suggest that patient girth at the level of the kidney may be a better factor to use than weight when 
selecting AA for this imaging task. 
Third, we proposed a general framework for using deep convolution neural networks as an 
anthropomorphic model observer for the task of interpreting 3D image volumes and reproducing 
human observer performance, and good results were obtained. The results showed that the 
DeepAMO has the potential to reproduce the performance of human observers on a clinically-
realistic defect detection task; absolute performance was not reproduced by a scanning model 
observer based on the optimal linear discriminant. The proposed framework could be readily 
adapted to model human observer performance on detection tasks for other imaging modalities 
such as PET, CT or MRI 
While this work provided several important steps towards the development of an improved 
dosing guidelines for pediatric molecular imaging, there is still work that remains to be done for 
establishing the data needed by standards bodies to develop improved dosing guidelines for 




6.3 Future works 
 
The findings in this dissertation suggest two areas of future work.  
First, the findings in Chapter 4 suggest a new direction to investigate the IQ-RD tradeoff 
relationships as functions of patient girth.  
Second, the major work in this dissertation was done using model observer. Image quality 
data only showed rankings as functions of AA but not absolute performance representing human 
performance. To translate the image quality measures to clinical use, it is more meaningful to 
provide an AUC value that would be obtained for a human observer. Thus, a human observer study 





This dissertation has provided useful direction and tool for a general framework for 
optimizing radiation dose with task-based assessment of image quality.  First, we demonstrated 
that the weight-based dose scaling does not equalize image quality, as measured by defect 
detectability, for patients with different weights. Second, we have found that patient body factors 
that are more local to the target organ may be more robust than weight for estimating the 
administered activity needed to provide a constant image quality across a population of patients. 
In the case of renal imaging, we have discovered that girth is more robust than weight in predicting 
administered activity needed to provide a desired image quality. Third, we have proposed a novel 
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deep learning-based anthropomorphic model observer that can efficiently simulate a realistic 
clinical realistic 3D detection task using multi-slice, multi-orientation image sets. 
The results of this dissertation provide a general framework, a new investigative direction 
(patient body factors local to the target organ), as well as tools (database, DeepAMO) for 
optimizing radiation dose with task-based assessment of image quality for nuclear medicine 
imaging. These results and methods from this dissertation will help provide the data needed by 
standards bodies to develop improved dosing guidelines for pediatric molecular imaging that result 
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